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ABSTRACT 
Liquid biopsy has the potential to enable diagnosis, prognosis, and monitoring of 
some diseases at an early stage using body fluids from patients. This minimally invasive, 
label-free detection method is less likely to harm the cell’s viability through binding to 
the surface protein. Smart integration of liquid biopsy designs with microfluidics on a 
single chip will lead to a considerable reduction in the detection time (due to controlled 
diffusion length), and the volumes of sample, agent and reagent, and the limit of 
detection.  
Optical label-free biosensors are a powerful tool to analyze biomolecular 
interactions and have been widely studied in the field of biomedical and biological 
science and engineering. Label-free detection enables direct measurement of key 
characteristic properties of the chemical compound, DNA molecule, peptide, protein, 
virus, or cell, while eliminating experimental uncertainty induced by the effect of the 
label on molecular conformation, thus reducing the time and effort required for bioassay. 
Existing optical label-free biosensors suffer from three limitations, including low 
detection sensitivity, slow molecules mass transfer, and poor throughput. The goal of this 
dissertation is to overcome these limitations through the development of a novel and 
efficient modality towards liquid biopsy-based bioassay with increased detection 
sensitivity, speed, and throughput.   
To increase the detection sensitivity, we investigate the optical bound states in the 
continuum (BIC) of slotted high-contrast grating (sHCG) structures. We demonstrate that 
the sHCG support BICs and high-Q resonant modes, and the slot position can be utilized 
to tune and optimize the linewidth of the high-Q resonances. To overcome the mass-
xvii 
transfer limitation and reduce the assay time, we propose a lateral flow-through optical 
biosensor integrating high-contrast gratings and microfluidics on a silicon-on-
insulator platform. The biosensor design allows reducing the diffusion length to a 
submicron scale and enhancing direct interactions between the analytes and 
sensing structures.  Finally, we develop a high-throughput, label-free exosome 
vesicles (EVs) detection microarray formed on a photonic crystal (PC) biosensor 
surface. We design and implement a hyperspectral imaging approach to quantify the 
antibody and EV absorptions on the PC-based microarray consisting of a panel of seven 
antibodies specific to multiple membrane receptors of the target EVs. We validate that 
the EV microarray by adopting it to detect EVs released by macrophages for the analysis 




CHAPTER 1.    INTRODUCTION 
 Background and Motivation 
Currently, existing optical label-free biosensors suffer from three major limitations: 
insufficient detection sensitivity, slow mass transfer, and poor throughput. This dissertation 
seeks to develop a new modality able to overcome these limitations. First, we describe the 
background of the optical label-free sensing. Then, we look into the challenges of label-free 
biosensors and come up with our solutions, including (1) designing high-contrast gratings 
with a high-quality (Q) factor to improve the detection sensitivity; (2) developing a rapid, 
lateral flow-through, optofluidic biosensor to overcome the mass-transfer limitation; and (3) 
developing a label-free imaging-based microarray to achieve the high-throughput molecular 
profiling of exosome vesicles (EVs). Lastly, we outline the work presented here.  
Liquid biopsy has significant advantages over traditional tumor biopsies [1-4]. 
Generally, cancer cells secrete cytokines, chemokines, and nucleic acids that have 
traditionally served as biomarkers for disease diagnosis and prognosis. Consequently, several 
detection assay methods have been developed to perform cell-based assays. The biosensor-
based detection approaches can be broadly classified into label-based and label-free types. 
Label-based detection relies on the specific properties of labels for detecting a particular 
target. For example, fluorescence labeling [5-9], chemiluminescence [10-12], and 
radiolabeling labeling [13-15] are three popular label-based techniques. The principle of the 
fluorescence biosensor is that the target molecules with labeled reagents, such as antigens 
with fluorophore are loaded on the surface immobilized by the probe molecules. Although 
fluorescence-based biosensors can be thought of as the short-time category of luminescence, 
the labeling of biomolecules with fluorescent or other similar tags for detection can result in 
2 
sample losses during the labeling and purification process and occasional loss of 
functionality. 
In contrast, label-free detection does not require labeling of ligand or receptor [16-
21]. Optical label-free biosensors can screen for biologically active molecular interactions 
and cellular responses, and provide detailed information on selectivity, kinetics, and binding 
affinity. The approach is suitable to detect target molecules that are not labeled or screen 
analytes that are not easy to tag. Because the label-free biosensors skip the labeling process, 
they can greatly simplify the time and effort required for assay development, thus offering 
rapid and simplified assays [22-30]. Among various biosensor systems, label-free optical 
biosensors often have faster response and higher signal-to-noise (S/N) ratio [31], and thus are 
regarded as a new generation of analytical modalities for studying biomolecular binding, 
recognition, and function.  
In the category of label-free biosensors, surface plasmon resonance (SPR) initially 
dominated commercial label-free biosensor solutions [32, 33]. Recently, other optical label-
free biosensors have emerged with much higher performances than SPR using various optical 
structures such as slot waveguide [34], ring and disk resonators [35], interferometer [36], and 
porous materials [37]. These new label-free biosensors have the potential to meet the 
biosensing need in the field of biomedical and biological science and engineering, including 
apoptosis, bacteriology, virology, molecular engineering, cell biology, cell adhesion, signal 
transduction, immune regulation, and enzyme mechanisms.  
 Photonic crystals and high-contrast gratings 
Clinical diagnostic assays require high sensitivity of label-free detection of 
biomolecules (e.g., virus, DNA, and proteins). Although most of the refractive index (RI) 
based biosensors have been proposed, high-quality (high-Q) optical sensors are perhaps the 
3 
most sensitive label-free sensors to enhance light interactions with the sensing target such as 
proteins. These biosensors use micro/nanophotonic structures to supports multi-pass light 
owing to the difference in refractive index between the photonic structures and surrounding. 
The light confinement leads to an increased effective interaction length, and thus a high-Q 
factor for obtaining high sensitivity of the sensors. 
Photonic Crystal (PC) is a periodic optical structure that has the dielectric constant 
variation to control the flow of light. A PC slab can be seen as a diffraction grating and a 
waveguide brought into proximity. It is often obtained by depositing a dielectric thin film 
with a relatively high refractive index onto a sub-wavelength periodic structure. The PC in 
the form of a sub-wavelength grating is essentially a narrowband optical reflector that 
reflects a particular wavelength of a broadband excitation.  
 
Figure 1-1 Theory of guided-mode resonance [38]. 
Guide-mode resonance (GMR) (shown in Figure 1-1) occurs when the diffracted 
mode and guided-mode meet the phase-matching condition. By taking the grating equation: 
𝑛2 sin[𝜃(𝑚)] = 𝑛1𝑠𝑖𝑛𝜃𝑖𝑛 −
𝑚𝜆0
Λ
𝑠𝑖𝑛𝜙   1-1 
4 
and the ray-tracing analysis: 
𝛽𝑚 = 𝑘0𝑛𝑒𝑓𝑓 = 𝑘0𝑛2sin⁡[𝜃(𝑚)]    1-2 
for a waveguide into account, the effective refractive index neff inside a 1D-PC can be 
described using Equation 1-3 : 
𝑛𝑒𝑓𝑓 = 𝑛1 sin 𝜃in − 𝑚
𝜆0
𝛬
                                                   1-3 
where n1 is the refractive index of the cladding layer, θin is the incident angle of the 
excitation, λ0 is the free space wavelength of the incident light, and Λ is the periodicity of the 
PC structure. The guided-mode represented when the condition satisfied: 
max[𝑛1, 𝑛3] ≤ 𝑛eff < 𝑛2                                                 1-4 
where n1 and n3 are the refractive indices of the cladding materials above or beneath the 
waveguide layer, respectively, and n2 is the refractive index of the waveguide layer. 
 
Figure 1-2 Schematic of the sHCG structure on an SOI substrate.  
A high contrast grating (HCG) is a planar subwavelength grating structure, where the 
grating material has a greater refractive index than its surrounding materials [39]. An HCG 
(shown in Figure 1-2) can be engineered to display strong broadband reflection and 
transmission, and narrowband high-Q resonances. Following the demonstration of broadband 
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reflection, recent studies have shown that an HCG also exhibits Fano resonances with a high- 
Q factor. In 1929, von Neumann and Wigner first proposed the possibility of BICs based on 
potential engineering [40]. Then, the possibility has been considered by Stillinger and 
Herrick [41]. More recently, Yoon et al. numerically investigated the TM-polarized optical 
bound states in the continuum (BIC) for a one-dimensional (1D) silicon grating [42]. In these 
devices, the optical bound states provide ideal confinement of light in the continuum of the 
free-space light cone. Although the BICs do not radiate, the high-Q modes with quasi-
embedded eigenvalues in the close vicinity of the BICs are particularly interesting, owing to 
their many potential applications to, e.g., optomechanics, nonlinear optics, cavity QED, and 
biomolecule detections. With regard to the HCG, the BICs play an important role in 
determining the characteristics of the radiative high-Q resonances. The underlying principle 
of guided-mode resonance (GMR) can be applied to understanding the resonances. For 
guided-mode resonance, the incoming light is coupled to the in-plane waveguide mode via 
the grating modulation with in-plane wave-vector:  
𝒌// = ?̂?𝑘0 𝑠𝑖𝑛 𝜃𝑖 ± ?̂?𝐺𝑥 ,     1-5 
where k0 = 2π/λ is the free-space wavenumber and Gx= 2mπ/Λ with an integer m. The in-
plane guided wave is scattered back into the continuum by the grating, and thus behaves as a 
leaky waveguide mode [43]. The constructive interference of the backward-scattered light 
with the zero-order reflection achieves a high-efficiency reflection. Meanwhile, the 
destructive interference of the forward-scattered light with the zero-order transmission 
produces a transmission minimum.  
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 Lateral flow-through assay 
1.3.1 Flow-through v.s. flow-over 
To date, most of the label-free sensors employ the “flow-over” scheme, where the 
analytes diffuse slowly from a bulk solution to the surface of a transducer and rely on the 
analytes in bulk solution to diffuse to the sensing surface (Figure 1-3(a)). This approach is 
simple and has been commonly used but suffers from the mass transport problems that 
negatively affect the detection limit and slow down the detection speed. Practically, 
molecules are dispersed in solutions and are free to diffuse into the liquid volume. When only 
a small number of molecules are studied, a large sensing area often produces a relatively poor 
signal-to-noise ratio. On the other hand, it has been demonstrated that when the sensing area 
is reduced to submicron dimensions and the concentration of the solution is on the order of 
femtomolar, the accumulation time for the detection of a few molecules would be on the 
scale of days. 
 
Figure 1-3 Issues with (a) conventional flow-over sensor and recent (b) vertical flow-through 
device 
To enhance the transport of analyte to the sensor surface, recently, some vertical 
flow-through scheme was implemented in a few label-free sensors [44-48], where an array of 
nanoholes is created in a suspended dielectric or metallic membrane to form a biosensor. 
These nanoholes allow the analytes to pass through the porous membrane (Figure 1-3(b)). 
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When the analyte transport and time response of the flow-through nanohole arrays is 
compared with the traditional flow-over sensors in a microchannel, the transport scaling 
analysis indicates that flow-through sensor exhibits a Peclet number 102-fold less than the 
flow-over scheme with the same flow rate. Also, a 20-fold faster time response is achieved 
for the flow-through case with rapidly diffusing analytes by compare with the flow-over case 
based on their experimental results [46].  
Due to the complex structure, these vertical flow-through devices are difficult to 
make and integrate with other functions (e.g., sorting) on a single chip. Therefore, a lateral 
flow-through device was proposed to not only overcome the issue of diffusion-limited 
detection that occurs in almost all conventional biosensors, but also largely simplify sensor 
design to achieve high S/N ratio and fast detection speed. Effective integration between 
label-free sensors and microfluidics is highly desirable for efficient sample delivery to 
achieve rapid and sensitive detection. Based on the flow over the structure, simply decreasing 
the height of the channel and increasing the fluidic velocity can shorten the analyte binding 
time. The diffusion limit will thus be overcome.  
We use the finite element method to model the kinetic response of the sensor as 
analyte molecules in the bulk solution are transported and diffused to bind with the capture 
antibodies available on the sensor surface. Three processes, including the sample transport, 
diffusion, and surface reaction, are modeled. 
1.3.2 Fluidic Kinetic analysis 
1.3.2.1 Laminar flow 
For the flow velocity field ?⃗? , the parabolic fluid flow velocity profile derived from 
the incompressible fluid Navier-Stokes equation with no-slip boundary condition was used. 
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The Navier-Stokes equation governs the motion of fluidics and can be seen as Newton’s 




+ ?⃗? ⋅ 𝛻?⃗? ) = −𝛻𝑝 + 𝛻 ⋅ (𝜇(𝛻?⃗? + (𝛻?⃗? )𝑇) −
2
3
𝜇(𝛻 ⋅ ?⃗? )𝐼) + 𝐹    1-6 
 
where ?⃗? is the fluid velocity, 𝑝is the fluid pressure, 𝜌is the fluid density, and 𝜇 is the dynamic 
fluid viscosity. 
1.3.2.2 Mass transport and diffused of diluted specious 
At the sensor surface, the kinetic sensor responds as the analyte molecules in the bulk 
solution are transported and diffused to bind with the capture molecules. The governing 
differential equation used for the analyte concentration in the bulk solution was the 
convection-diffusion equation listed below as 
∂𝑐𝐴
∂𝑡
+ ∇ ⋅ (−𝐷∇𝑐𝐴 + 𝑐?⃗? ) = 0     1-7 
where 𝑐𝐴, 𝐷, and ?⃗?  are the bulk analyte concentration, bulk diffusion constant, and fluid flow 
velocity vector, respectively.  
1.3.2.3 Surface reaction 
For a one-to-one interaction in solution observed is between an immobilized ligand A 
and soluble ligate B, which can form a complex AB, for the reversible interaction, 
𝐴 + 𝐵
 𝑘𝑎𝑘𝑑 
⇄ 𝐴𝐵     1-8 
The rate of formation of AB complexes at the time t may be written as 
𝑑[𝐴𝐵]/𝑑𝑡 = 𝑘𝑎[𝐴][𝐵] − 𝑘𝑑[𝐴𝐵]     1-9 
where 𝑘𝑎 is the association rate constant and 𝑘𝑑 is the dissociation rate constant. After some 
reaction time t, [𝐵] = [𝐵]0 − [𝐴𝐵], substituting into equation (b) gives 
𝑑[𝐴𝐵]/𝑑𝑡 = 𝑘𝑎[𝐴]([𝐵]0 − [𝐴𝐵]) − 𝑘𝑑[𝐴𝐵]    1-10 
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where [𝐵]0 is the total concentration of reactant B at t = 0. 
In the biosensor, one of the reactants is immobilized to the sensor surface, and the 
other is continuously replenished from a solution flowing past the sensor surface. The 
response cAB corresponds to the amount of AB complexes formed, and the maximum 
response 𝜃0 is proportional to the surface concentration of immobilized ligand. The rate 
equation can thus be written as 
𝑑𝑐𝐴𝐵/𝑑𝑡 = 𝑘𝑎𝑐𝐴(𝜃0 − 𝑐𝐴𝐵) − 𝑘𝑑𝑐𝐴𝐵    1-11 
where 𝑑𝑐𝐴𝐵/𝑑𝑡is the rate of the formation of surface complexes, 𝑐𝐴 is the concentration of 
the analyte in free solution (which is the constant), 𝜃0is the total amount of binding sites of 
the immobilized ligand, and 𝜃0 − 𝑐𝐴𝐵 is the amount of remaining free binding sites at time t.  
At the biosensor surface, the boundary condition is represented by coupling the rate 
of reaction at the surface with the flux of the reacting species and the concentration of the 
adsorbed species and bulk species as 
𝑁 = 𝑘𝑎𝑐𝐴(𝜃0 − 𝑐𝐴𝐵) − 𝑘𝑑𝑐𝐴𝐵    1-12 
where N is the adsorption and desorption of analyte at the reactive surfaces give rise to a net 
flux, which represents ?⃗? ⋅ (−𝐷𝛻𝑐𝐴 + 𝑐?⃗? ). At the inlet of the channel where the analyte 
solution is introduced, the boundary condition used here is 𝑐 = 𝑐0. At the outlet, the outflow 
condition is defined as ?⃗? ⋅ (−𝐷𝛻𝑐) = 0, and the boundary condition of the channel wall is 
defined as ?⃗? ⋅ (−𝐷𝛻𝑐𝐴 + 𝑐?⃗? ) = 0. For the FEM simulation, the association rate constant and 
dissociation rate constant of ka = 1×10
7 (mol/L)-1s-1 and kd = 0.01 s
-1 are used. For the surface 
of the capture antibody, θ0 = 5×10
-8 mol/m2 is used. For the flow velocity within the channel, 
a Gaussian distribution profile with a velocity of 0.04 m/min is used. For the diffusion 
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can be calculated to be 1.2×10-7 m/s. 
 
Figure 1-4 The binding process of the analyte molecules and sensor surface with (a) different 
channel height. (b) different velocity. 
Figure 1-4 (a) compares the assay performance for the scenario in which the sensor is 
placed in the channel with the height h = 0.5 μm, 10 μm, 20 μm, and 50 μm, respectively. 
The height of 0.5 μm corresponds to the flow-through sensor, where the sample only flows 
within the interstitials between the nanoposts. Our results show that the flow-through scheme 
dramatically reduces the time (teq) required to establish steady-state equilibrium. For the 
flow-through assay, the sensor response saturates after 10 min of sample flow. Furthermore, 
we studied the kinetic binding response as a function of sample flow rate (Figure 1-4 (b)). 
High flow rates could result in shorter teq. These results will be used to guide the design of 
the sensor system. 
 Microarray imaging 
Sensitivity and throughput are two key points to evaluate the performance of a label-
free biosensor. We propose a high-contrast grating with a high Q-factor to increase the 
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sensitivity. To maximize the throughput of measurements, we propose a high-throughput 
microarray device that simultaneously performs multiple measurements on a single chip.  
Generally, a microarray consists of surface-immobilized biomolecules such as DNAs, 
proteins, and carbohydrates. These biomolecules are spotted, imprinted, or directly 
synthesized on glass or silicon wafers, or other functionalized surfaces. Edwin M. Southern 
proposed the first simple DNA arrays, which they called “dot blots” in 1975 [49]. Later, 
Fodor et al. fabricated a DNA microarray on glass chips of using photolithographic light-
directed synthesis method in 1991 [50]. Figure 1-5 shows the fluorescence scan of an array of 
1024 peptides generated by a ten-step binary synthesis. Many different types of microarray 
technologies have been developed, and a variety of DNA microarray and DNA chip devices 
and systems have been commercialized. These microarray systems are being used for gene 
expression, genotyping, and other applications.  
 
Figure 1-5 Fluorescence scan of an array of 1024 peptides generated by a ten-step binary 
synthesis [50].  
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Surface plasma resonance imaging (SPRi) microscopy (Figure 1-6) is a well-known 
label-free biosensor technique. SPR is suitable for studying interactions between different 
biomolecules in real-time and refers to the resonant oscillation of conduction electrons at the 
interface between negative and positive permittivity material stimulated by incident light. 
The SPRi measures the reflection coefficient of monochromatic incident light at a fixed angle 
and fixed wavelength. In this system, an expanded and collimated light is incident over the 
entire sensor surface. The microarray will be detected, and the reflection coefficients at 
different locations of the array will be imaged by using a closed-circuit display (CCD) 
camera. Biomolecule binding will change the surface refractive index, and the intensity of 
the reflected light in the corresponding CCD pixel will change proportionally. Therefore, 
combining the SPRi with microarray technologies allow high-throughput detection of 
biomolecule interactions.  
 
Figure 1-6 Surface plasmon resonance imaging (SPRi) microscopy [51]. 
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SPRi requires illumination to pass through biomolecules that introduce changes in 
reflected light intensity that are not related to the surface attachment of the biomolecules. 
Also, the lateral propagation distance of surface plasmons limits spatial resolution [52]. 
Therefore, among the earliest developed label-free imaging modalities based on the PC 
biosensors [53-55], PC Enhanced Microscopy [53-59] represents a new form of optical 
microscopy that uses a PC surface to dynamically detect and visualize biomaterial-surface 
interactions (Figure 1-7).  
 
Figure 1-7 Transmission acquisition mode of photonic crystal biosensor integrated with an 
upright imaging microscope and using laser as light source. (A) Schematic of combined 
label-free and enhanced-fluorescence imaging instrument; (B) Enhanced (a) fluorescence and 
(b) label-free images on a PC biosensor. [60] 
 Dissertation organization 
In this dissertation, I will first introduce a few key concepts extensively used in this 
work in Chapter 1, including the PC and HCG structures, GMRs, label-free biosensors, and 
flow-through biosensors.  
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In Chapter 2, slotted high-contrast gratings or sHCGs are developed, and the BIC 
modes are studied. The eigenvalue solver is used to determine the BICs. Also, the high-Q 
resonance phenomena for both TE (transverse electric)- and TM (transverse magnetic)-
polarized cases are investigated. The sHCG device has a high index sensitivity of 368 
nm/RIU (refractive index unit), thus showing the promise to explore refractive index-based 
sensing using the sHCG device. 
In Chapter 3, based on, an HCG-based lateral flow-through biosensor is developed for 
the detection of cancer biomarker. The sensor design overcomes the mass transfer limitation 
and reduces the limit of detection. The biosensor is formed using the CMOS-compatible 
silicon-on-insulator technology.  
In Chapter 4, we develop a label-free PC based biosensor for rapid and specific 
discrimination of murine host exosome vesicles (EVs) from parasite EVs extracted from the 
culture media. 
In Chapter 5, a high-throughput EV detection assay is developed using a label-free 
EV microarray. The EV microarray enables low-cost, rapid, and high-throughput 
characterization of macrophage EVs.  
In Chapter 6, we conclude this dissertation and look into our future work. 
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CHAPTER 2.    OPTICAL BOUND STATES IN SLOTTED HIGH-CONTRAST 
GRATING 
 Abstract 
This chapter investigates the optical bound states in the continuum (BIC) supported 
by a slotted high-contrast grating (sHCG) structure. The sHCG structure consists of a 
periodic array of silicon ridges with a slot in each ridge. Given that the BICs are perfectly 
confined, their spectral locations are identified using a finite-element method formulated 
from a generalized eigenvalue problem. The real eigenvalues represent the wavelengths of 
BIC modes and the associated eigenvectors correspond to the electric field distributions. In 
the spectral and angular vicinity of the BICs, the leaky waveguide modes are studied using 
the rigorous coupled-wave analysis. The combination of the full-wave eigenvalue solver and 
the coupled-wave analysis provides an ideal setting for investigating the optical BICs of 
periodic structures for various applications. For example, the simulation results show that the 
sHCG structures can support symmetry-protected bound states with zero in-plane wave 
vector as well as high-quality-factor (high-Q) resonances for both TE and TM polarizations. 
By adjusting the slot, the BIC mode can be turned into high-Q modes and the linewidth of the 
mode is determined by the degree of asymmetry. 
 Introduction 
Dielectric slabs with periodic sub-wavelength features, such as photonic crystal slabs, 
guided-mode resonance filters, and high-contrast gratings (HCG), have attracted considerable 
attention for their fascinating optical properties caused by the modulation and confinement of 
light [39, 61-66]. Previous studies carried out on these devices have demonstrated numerous 
applications to high-performance optical filters [67-71], solid-state light sources [72, 73], 
nonlinear optics [74-78], biomolecule detection [79, 80], to name but some. Among the 
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grating-patterned slabs, the HCG structure, built upon a silicon-on-insulator substrate, is 
particularly interesting, owing to its extraordinary optical properties and compatibility with 
the complementary metal-oxide semiconductor process [81]. As reported by Mateus et al. 
[82] and Shokooh-Saremi et al. [83], a HCG device allows broadband reflection with a 
reflectivity more than 99% in the near-infrared wavelength regime. Following the 
demonstration of broadband reflection, recent studies have shown that a HCG device also 
exhibits Fano resonances with a high-quality factor (Q factor). In 1929, von Neumann and 
Wigner first proposed the possibility of BICs based on potential engineering [40]. Then the 
possibility has been considered by Stillinger and Herrick [41]. More recently, Yoon et al. 
numerically investigated the TM-polarized optical bound states in the continuum (BIC) for a 
one-dimensional (1D) silicon grating [42]. 
The existence of a perfectly confined optical mode within the radiation continuum 
was shown using a parallel dielectric grating [84], 1D periodic array of dielectric rods and 
spheres [85, 86], and two-dimensional photonic crystal slab [87-92] that supported a 
scattering resonance with a vanishing linewidth. A recent seminal work by Hsu et al. shows 
experimentally demonstrated the BICs of a2D Si3N4 photonic crystal slab [93]. Later, layered 
sub-wavelength nanoparticles were numerically designed to achieve the BIC in three-
dimensional open scattering systems [94]. For these devices, the optical bound states provide 
an ideal confinement of light in the continuum of the free-space light cone. Although the 
BICs do not radiate, the high-Q modes with quasi-embedded eigenvalues in the close vicinity 
of the BICs are particularly interesting, owing to their many potential applications to, e.g., 
optomechanics, nonlinear optics, cavity QED, and biomolecule detections. With regard to the 
HCG, the BICs play an important role in determining the characteristics of the radiative high-
17 
Q resonances. However, the relations between the broadband reflective modes, high-Q 
modes, and BICs have not yet been systematically studied.  
 
Figure 2-1 Schematic of 1D sHCG structure on a SiO2 substrate. (Not to scale). The 1D 
sHCG consists of an array of slotted nano-ridges. The device is excited by a plane wave at an 
incidence angle of θi. The TE- and TM-polarized modes correspond to the modes with the 
electric field component parallel and perpendicular to the grating lines, respectively. 
     This paper investigates the TE- and TM-polarized BICs and high-Q resonance 
modes of a silicon-based slotted HCG (sHCG). As shown in Figure 2-1, the sHCG has a 
rectangular nanoslot cut into each ridge of the grating. The position of slot in the ridge can 
determine the resonant characteristics of the device. Since the slot can be fabricated along 
with the HCG structure using a lithography process, the proposed structure is ready for 
manufacture. Although previous studies utilized rigorous coupled-wave analysis (RCWA) or 
a finite-difference time-domain method to identify BICs in an asymptotic manner [42], none 
of these studies directly calculated the eigenfrequency of the resonance modes that do not 
interact with the radiation continuum. Here, we employ a finite-element method (FEM) to 
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solve the eigenvalue problems for the periodic structures, and consequently determine the 
resonance wavelengths (λr) and the associated mode distributions. The eigenvalue analysis 
shows that the BIC wavelengths increase proportionally with increasing grating period and 
that the number of BICs increases with increasing sHCG thickness. To acquire an in-depth 
understanding of the phenomena associated with the BICs, we calculated the spectral and 
angular reflectance of 1D SHCG structures. Furthermore, we show that breaking the 
symmetry in the grating design produces a transition of a BIC mode to a high-Q mode.  
      This paper is organized as follows. Section 2 specifies the SHCG structures and 
Section 3 describes the numerical methods used to analyze and simulate the phenomena of 
interest. Section 4 describes the bound states of the 1D sHCG device for two different 
polarizations. Section 5 demonstrates the possibility of forming an asymmetric SHCG 
structures to turns BICs into high-Q resonances. Section 6 provides concluding remarks. 
 Definitions, phenomenology, and characterization techniques 
2.3.1 sHCG structure and physical principles 
The sHCG structure used in this study consists of a periodic pattern made of silicon 
and formed on a 3-μm-thick SiO2 buffer layer. The main geometric parameters are the 
grating period (Λ1D), grating width (wg), slot width (ws), nanoslot offset from the grating 
center (ds), grating-layer thickness (tg), and duty cycle (η = wg/Λ), as depicted in Figure 2-1. 
For the symmetry protected structure, the slot stands at the middle of the ridge, which ds = 0. 
The period of 1D arrays is smaller than the free-space wavelength λ. The thin device layer of 
silicon can be patterned by lithography, followed by a reactive-ion etching process [95]. 
Crystalline silicon is a suitable material for fabricating high-Q optical devices because it is 
transparent in the near-infrared regime, with a negligible extinction coefficient κ < 0.001 and 
a large refractive index n = 3.477. A plane-wave excitation beam is shone on the device from 
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the grating side. As shown in the schematic view of the sHCG devices (Figure 2-1), the 
incident angle θi is measured from the normal of the grating surface Incident plane waves 
with their electric field polarized parallel or perpendicular to the grating bars are described as 
having transverse-electric (TE) or transverse-magnetic (TM) polarizations, respectively.  
      Optical phenomena supported by HCGs and their underlying principles have been 
described previously. [38, 42, 96-98] Briefly, a HCG structure can be engineered to display 
strong broadband reflection and transmission, and narrowband high-Q resonances. The 
underlying principle of guided-mode resonance can be applied to understanding the 
resonances. For guided-mode resonance, incoming light is coupled to the in-plane waveguide 
mode via the grating modulation with in-plane wavevector:  
𝒌// = ?̂?𝑘0 𝑠𝑖𝑛 𝜃𝑖 ± ?̂?𝐺𝑥 ,     2-1 
where k0 = 2π/λ is the free-space wavenumber and Gx= 2mπ/Λ with an integer m. The 
in-plane guided wave is scattered back into the continuum by the grating, and thus behaves as 
a leaky waveguide mode [43]. The constructive interference of the backward-scattered light 
with the zero-order reflection achieves a high-efficiency reflection. Meanwhile, the 
destructive interference of the forward-scattered light with the zero-order transmission 
produces a transmission minimum. The BIC characteristics can be simulated using 
electromagnetic simulations as discussed below. 
2.3.2 Numerical characterization techniques 
RCWA and the finite-difference time-domain method have previously been used to 
study HCG devices and photonic crystals [42]. These methods can simulate the optical 
phenomena that occur in a structure in response to excitation, and yield the reflectance, 
transmittance, and near-field distribution that can then be used to guide nanostructure design. 
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However, these methods are unable to find non-radiative BICs directly. We therefore 
developed a generalized eigenvalue problem using an FEM-based solver to find all the BICs 
supported by the sHCG structure. The FEM simulation model included only one period of 
the sHCG structure. The periodic boundary condition in the x-direction, together with the 
perfectly matched layers in the z-direction, defined the simulation domain in the x-z plane. 
The simulation domain was discretized using a triangular mesh. By basing the finite-element 
analysis on the electric-field discretization, the variational problem that is equivalent to the 
wave equation (source-free) led to a generalized eigenvalue problem [99]. By solving the 
generalized eigenvalue equation, the eigenvalue solver yielded the eigenvalues and 
eigenvectors, which represent the resonance wavelength and electric field, respectively. Only 
the real eigenvalues correspond to the bound states with a radiative coupling coefficient of 
zero (κ = 0). For the sHCG structure shown in Figure 2-1, we used the eigenvalue solver to 
determine the BICs for different device geometries. The details and equations involved in the 
FEM analysis are given in the Appendix. 
     After finding the BICs, we used the RCWA method to study the BICs in an 
asymptotic manner. The RCWA algorithm is based on the Fourier expansions of the 
electromagnetic fields and the permittivity profiles (εr(x, y)) in each layer of a periodic 
structure. The diffraction efficiencies for each harmonic in the Fourier expansion were 
calculated to determine the reflectance or transmittance. The analysis was carried out using a 
commercial RCWA software package (DiffractMOD, Synopsis). The RCWA simulation was 
set up to analyze a unit volume of the HCG structures, and periodic boundary conditions 
were applied to define the calculation domain, as labeled by the dashed box in Figure 2-1. 
Twenty harmonics were used to expand the permittivity and fields along the x-direction. The 
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dispersive and complex refractive indices of crystalline silicon, n(λ) = nsi(λ) + iκsi(λ), were 
taken from Palik’s handbook [100], where nsi = 3.486 + i0.001 at λ = 1550 nm. The reflection 
and transmission spectra were calculated in the desired near-infrared wavelength range. 
 Eigenvalue analysis of silicon-based sHCGs 
The eigenvalue solver was applied to study how the geometric parameters of the 
silicon grating affect the BICs and illustrate the principles behind the sHCG-supported BICs. 
Material loss was neglected by assuming κsi = 0, leaving out-of-plane scattering as the only 
loss mechanism. As a result, the real eigenvalue solutions correspond to the perfectly 
confined BICs and those with an imaginary part are associated with the modes coupling with 
the radiation continuum. To characterize resonances supported by sHCGs with different 
grating periods, we considered sHCG structures with a thickness, duty cycle, slot width of tg 
= 500 nm, η = 50%, ws = 50 nm, respectively. As for the periodic boundary condition 
described in Eq. A (3), the phase shift was set to 𝜙 = 0, representing the normal incidence 
case with θi = 0°. The grating period ranges from Λ = 500 to 1800 nm with the increment of 
50 nm. Eigenvalues were solved for each grating period, but only the real eigenvalues are 
plotted in Figure 2-2(a) as the BIC resonant wavelengths. The eigen-wavelengths can be 
grouped into three branches. The two branches shown in black represent the TE modes (TE10 
and TE11) and the one shown in red is the TM10 mode. The modes are labeled as TEmn (or 
TMmn), where the integers m and n are determined by the distribution of the longitudinal 
component of the field along x- and z-axes, respectively. The polarizations of these modes 
were determined by the electric-field components given by the eigenvectors. Here, the high 
refractive index grating-patterned silicon slab provides the in-plane confinement. The Bragg 
condition gives the resonance wavelength,  
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λ = 2n𝑒𝑓𝑓Λ/𝑚     2-2                                                       
where neff is the effective waveguide index and m is a positive integer that denotes the 
order of diffraction. According to the Bragg condition, the resonance wavelength increases 
with the grating period, in agreement with the simulation results shown in Figure 2-2(a).  
 
Figure 2-2 Eigen-wavelength calculated as a function of (a) the grating period and (b) the 
grating thickness (c) the slot width. (d) Eigenvectors of the TE10, and TE11 modes when Λ = 
880 nm, η = 50%, and ws = 50 nm labeled by the blue line. For the TE modes, the Ey 
components at the corresponding wavelength 2012 nm and 1519 nm are plotted in the upper 
and lower panels, respectively. (e) Eigenvectors of the TM10 mode. The Ex and Ez 
components of the TM10 mode are shown in the top and lower panels at λr = 1459 nm. 
     Figure 2-2(b) shows the eigen-wavelengths calculated as functions of the grating 
thickness when the grating period and duty cycle are fixed at Λ = 880 nm and η = 50%, 
respectively. The grating thickness increases from tg = 50 to 1200 nm with the increment of 




2 , where 
navg can be estimated using the average refractive index of the patterned slab. As shown in 
Figure 2-2(b), the number of BIC modes increases with increasing grating thickness. Single-
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mode operation occurs when the grating thickness is less than 200 nm. For each mode, the 
BIC wavelength shifts to the red end as the grating thickness increases. Figure 2-2(c) shows 
the eigen-wavelengths calculated as a function of the slot width ranging from 10 nm to 100 
nm. As shown in the Figure 2-2, the BIC wavelength decreases when the slot widens for all 
three modes (TE00, TE11, and TM10). The blueshift of the resonant wavelength is owing to the 
decrease of the averaged refractive index when the slot becomes wider.  
      Next, the field distributions of the BICs were studied using the eigenvectors 
associated with the real eigen-wavelengths. To this end, we considered a 1D sHCG device 
with grating period Λ = 880 nm, grating thickness tg = 500 nm and slot width 50 nm. This 
particular device supports three BICs at λr = 1455.1, 1558.4, and 2018.7 nm, respectively. 
The modes at λr = 1455.1 and 2018.7 nm are TE-polarized modes with only the Ey 
components shown in the top and bottom panels of Figure 2-2(d). The eigenvectors of the Ex 
and Ez components are trivial and are therefore omitted from the Figure 2-2. The mode at λr = 
1558.4 nm is a TM-polarized mode with its Ex and Ez components shown in Figure 2-2(e). 
Being a TM mode, its Ey component is trivial compared to the Ex and Ez components. The 
resonant field distributions indicate that the order of Bragg diffraction is m = 2. We note that 
the distributions of the resonant fields are antisymmetric and these modes can be considered 
to be symmetry-protected bound states. The coupling to the continuum in the surface-normal 
direction is forbidden because of symmetry incompatibility with the external radiation, 
whose tangential field components are symmetric with respect to the mirror-symmetry axis at 
x = 0. The BIC mode is distinct from the resonance of a distributed-feedback (DFB) cavities 
[101] because they reside inside the light cone of a photonic band diagram, shown in the 
following section. Moreover, we sought the real eigenvalues of the sHCG with the incident 
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light at an oblique angle (0° < θi < 90°). For the structure shown in Figure 2-1(a), real 
eigenvalues are only present when θi = 0°.  
 
Figure 2-3 TM-mode characteristics. (a) Calculated reflection spectra in the wavelength 
range 1200 to 2200 nm, for incident angles ranging from -15° to 15°. (b) the reflection 
spectra calculated for θi = 0°, 0.5°, 1°, 2°, and 5°. The corresponding linewidths for each 
angle are plotted in the inset. (c) The near-field distributions of Ex, Ez, and Hy components 
for the high-Q resonance (Q factor = 1.7 × 105) at λr = 1458.3 nm and θi = 0.01°. 
 Broadband, BIC, and high-Q modes 
The sHCG device can be designed to exhibit a single BIC mode when tg < 200 nm. 
To illustrate the couplings between the broadband reflection, the high-Q mode, and the BIC, 
we selected a design that supports both TE and TM modes. The device consists of a grating 
with period Λ = 880 nm, thickness tg = 500 nm, and slot width ws = 50 nm. As shown in 
Figure 2-2 (a) and (b), there should be two TE modes and one TM mode. We first study the 
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TM mode. The calculated reflection spectra are plotted as functions of the incident angle in 
Figure 2-3(a). The wavelength and incident angle range from 1200 to 2200 nm and from -15° 
to 15°, respectively. The TM-polarized resonances appear as reflection peaks. In contrast, the 
HCG structure without the slot exhibits the TM-polarized resonances as narrowband dips 
[102]. In Figure 2-3(a), the region indicated by the red box contains the BIC and high-Q 
modes. To elaborate on these phenomena, the reflection spectra calculated for θi = 0°, 0.5°, 
1°, 2°, and 5° are compared in Figure 2-3(b). The resonant linewidth decreases significantly 
as the incidence angle approaches 0°. For example, when the incident angle is 1°, the 
resonance linewidth is 1.1 nm, which corresponds to a Q factor of 1305.  In comparison, the 
Q factor increases to 4766.6 nm when θi is reduced to 0.5°. The vanishing of the linewidth at 
θi = 0° implies the existence of BIC. As shown in Figure 2-3(b), the BIC mode locates at λr = 
1458 nm in the spectrum, in agreement with the eigenvalue analysis. Because the TM mode 
displays a weak reflection in the spectral range of interest, the high-Q resonance modes are 
displayed as peaks with a high reflectance at the resonant wavelength. 
      The near-field distribution of a representative high-Q mode is calculated using the 
RCWA simulation and shown in in Figure 2-3(c). Here, the near-field distributions of the Ex, 
Ez, and Hy components are associated with the high-Q resonance (Q factor = 1.3 × 10
5) at λr 
= 1458.3 nm and θi = 0.01°. The color axis expresses the amplitudes of the electric and 
magnetic fields, normalized by that of the incident field. As seen from the field distributions, 
the maximum field enhancement factor is 1500. The enhancement factor of the field intensity 
is calculated by averaging the electric field intensities within the sHCG area (- Λ /2 < x < Λ /2 
and 0 < z < tg). As a result, the averaged enhancement factor of the field strength is 
approximately 1.7 ×105. The distributions of the tangential components (Ex and Hy) are 
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asymmetric. The mode can be excited because the asymmetric nature of the incident wave at 
θi = 0.01°. 
 
 
Figure 2-4 Characteristics of the TE-mode. (a) Calculated reflection spectra in the 
wavelength range of 1200 nm to 2200 nm as a function of incident angles from -15° to 15°. 
(b) The reflection spectra calculated for θi = 0°, 0.5°, 1°, 2° and 5° for the modes around 
2012.9 nm. (c) The reflection spectra calculated for θi = 0°, 0.5°, 1°, 2° and 5° for the modes 
around 1519.7 nm. The corresponding of linewidth for each small angle shown in inset. (d) 
The near field distributions of Ey, Hx, and Hz components with the high-Q resonances (Q 
factor = 4 × 107) at λr = 2012.9 nm and θi = 0.01° for TE10 (top) and TE11 (bottom) mode, 
respectively. 
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     Having characterized the TM mode, we used the same approach to study the TE-
polarized modes. Figure 2-4(a) shows the reflection spectra of the TE modes plotted as a 
function of the incident angle, which ranges from -15° to 15°. As shown in Figure 2-2(b), 
there are two TE-polarized BIC modes (TE10 and TE11) when the silicon grating thickness is 
500 nm. In Figure 2-4(a), the regions of the TE resonances are outlined by the black (TE10 
mode) and white boxes (TE11 mode), respectively. Figure 2-4 (b) and 4(c) summarizes the 
reflection spectra for θ = 0°, 0.5°, 1°, 2°, and 5° for the TE10 and TE11 modes, respectively. 
Like the TM resonances, the TE modes also display as peaks in the reflection spectra. Also, 
the TE resonance linewidth decreases as the incidence angle approaches 0° and disappears at 
θ = 0°. This phenomenon indicates the existence of the BICs at λr = 1519 and 2012 nm. The 
near-field distributions of a representative high-Q mode for two TE modes are plotted, as 
obtained using the RCWA simulation. Figure 2-4(d) shows the amplitude distribution of the 
Ey, Hx, and Hz components that are associated with the high-Q resonance at θi = 0.01° for the 
TE11 mode at λr = 1519.7 nm (top row) and the TE10 mode at λr = 2012.9 nm (bottom row). 
The tangential components (Ey and Hx) of these mode are clearly asymmetric. The near fields 
of both TE modes are significantly enhanced relative to the incident wave. 
 Asymmetric sHCGs 
In the previous section, we showed that the transition from a BIC mode transit to a 
high-Q resonant mode when the sHCG is illuminated from an off-normal direction (0° < θ < 
1°). Recent research demonstrated an approach for transforming the perfectly confined mode 
to high-Q resonances using non-equivalent sub-cells in one period of the grating [103]. Since 
the BIC mode with kx = 0 is symmetry-protected, an asymmetric design of the sHCG can be 
exploited to eliminate the BIC and tune the high-Q resonant modes. This section 
28 
demonstrates another approach that allows the precise control of the resonance using the slot 
position.  
 
Figure 2-5 Asymmetric sHCG structure. (a) Schematics of sHCG, where the position of slot 
is shifted from the ridge center by a distance of ds. (b) The reflection spectra for the 
asymmetric grating with ds = 1, 5, 10, 20, and 40 nm. (c) The Q factors are plotted as 
functions of ds. 
As shown in Figure 2-5(a), we shift the slot from the center of the ridge to the right 
(or left) side with an offset of ds. The shift of the slot results in an asymmetric sHCG 
structure.  As a result, the symmetry-protected BIC mode disappears, and all the eigenvalues 
are complex. The resonant wavelength and the Q-factor are associated with the shift distance. 
Using the RCWA simulation, we studied the reflection characteristics of the asymmetric 
sHCG with the slot at off-center positions. Figure 2-5(b) shows the reflection spectra for ds = 
1, 5, 10, 20, and 40 nm, respectively, for the TM10 mode. The incident angle is kept at θi = 0° 
and the slot width is set as ws = 50 nm.  The resonant wavelength increases while the position 
of slot moves. It is clear that the resonant linewidth significantly increases as the slot 
approaches edge of the ridge. The device with the ds as small as 1 nm exhibit the linewidth of 
0.004 nm and the Q-factor of 3.6 × 105. Increasing ds to 5 nm broadens the resonant 
linewidth to 1 nm (Q-factor of 1451). To elaborate how the resonance characteristics of the 
asymmetric SHCG resonator can be tuned, we summarized the Q factor as a function of slot 
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position in Figure 2-5(c). As shown in the figure, the Q-factor decreases exponentially with 
the shifting of the slot towards the edge of the ridge.  
 
Figure 2-6 Resonant characteristics of the asymmetric sHCG structure. (a) and (b) Resonant 
wavelength and loss as a function of slot position for TE10, TE11, and TM10 modes, 
respectively. (c) Reflection spectra for the asymmetric sHCG devices with ds = 80, 120, and 
140 nm, respectively. 
      We also used the eigenvalue solver to study the resonant wavelength and loss of 
the asymmetric sHCG devices. In the case of ds ≠ 0, all the eigenvalues are complex 
numbers. The real part of the complex number is the resonant wavelength of the asymmetry 
sHCG. Figure 2-6(a) shows the calculated eigen-wavelength as a function of the slot 
position. The resonant wavelengths of both TE01 and TE11 modes decrease with the moving 
of the slot away from the center of the ridge. On the other hand, the resonant wavelength of 
the TM10 mode increases while increasing the ds. The breaking of device symmetry 
introduces radiation loss, which depends on the position of the slot. The radiation loss can be 
calculated using the imaginary part of the eigenvalues when ds ≠ 0. Figure 2-6(b) shows the 
change of radiative loss as a function of the slot position. For all three modes, the loss is 
strong when the sHCG has the highest degree of asymmetry, which the center of the slot will 
be located at wg/4 = 110 nm. Thus, the loss achieves maximum when ds is approximately 85 
nm. The BICs exist with zero radiative loss when the slot locates at the middle of the ridge 
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(ds = 0) and the boundary of the ridge (ds = 84.3 nm). Figure 2-6(c) shows the reflection 
spectra when ds = 80, 120, and 140nm, respectively. When ds increases beyond 80 nm, the 
resonant linewidth starts to decrease. 
 Conclusion 
Optical bound states and the associated high-Q resonant modes supported by silicon-
based sHCG structures were studied numerically. Special attention was given to the FEM 
eigenvalue solver, which is capable of finding the resonant wavelength and the near-field 
distributions of the BICs. The results show that the number of bound states supported by a 
SHCG structure is determined by the silicon slab thickness. Using the calculated eigen-
wavelengths, RCWA simulations were performed to characterize the resonant modes that are 
spectrally and angularly close to the BICs. The sHCG design investigated above displays one 
TM-polarized and two TE-polarized BICs. The TE- and TM-polarized resonances appear as 
narrowband peaks in the reflection spectra. Because the BICs are perfectly confined bound 
modes, they cannot be excited. The simulation of an asymmetric sHCG structure 
demonstrates that the BIC mode can be turned into a high-Q resonance, with the Q factor 
being controlled by the degree of asymmetry. 
The BIC and neighboring resonant modes of the sHCG structure can be applied to the 
construction of high-Q optical resonators in the fields of optomechanics, nonlinear optics, 
and cavity QED with a tunable Q-factor by changing the coupling angle. They can also be 
used for refractive index-based biomolecule detection. The numerical techniques presented in 
this paper enable both source-excited and source-free assessments of BICs in slabs with a 
patterned grating. Understanding the phenomena above is an important step towards 
exploring more complex mechanisms involving the couplings between free-space fields, 
BICs, and high-Q modes. 
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 Appendix: Governing equations for the FEM eigenvalue solver 
The electric field in the sHCG structure satisfies the second-order wave equation 
                   𝛻 × 𝜇𝑟




)𝑬 = 0,     inΩ   2-3 
and is subject to the following condition for a perfect electric conductor and floquet 
boundaries: 
                              ?̂? × 𝑬 = 0        onΓ1    2-4 
                            𝑬𝐹𝑙 = 𝑒
𝑖𝜙𝑬𝐹𝑟     onΓ2    2-5 
where Γ1 and Γ2 are the boundaries along the z- and x-axis, respectively. In equation 2-
3, the relative permeability μr = 1, and σ and εr denote the relative permittivity and 
conductivity. In equation 2-5 𝑬𝐹𝑟and 𝑬𝐹𝑖are the fields at x = 0 and Λ, respectively, and the 
phase shift is given by 𝜙 = 𝑘𝑥Λ = 𝑘0 sin 𝜃𝑖Λ. Perfect matching layers (PMLs) are applied 
along the z-direction to absorb the outgoing waves. In the PML regions, the anisotropic 
absorber model is used to create a reflection free interface [104]. Then, by applying the 
variational principle, the solution to the problem defined by equation 2-3 - 2-5 is equivalent 
to 
𝐹(𝑬) = ∬ [𝜇𝑟




   2-6 
To solve equation 2-6, the electric field in the computation domain is discretized 
using the triangular elements,  
                  𝐸𝑡
𝑒 = ∑ 𝑒𝑡𝑖
𝑒𝑛
𝑖=1 𝑁𝑖
𝑒  and 𝐸𝑧
𝑒 = ∑ 𝑒𝑧𝑖
𝑒 𝜁𝑖
𝑒𝑛




𝑒  denote the vector expansion functions and the corresponding 
expansion coefficients. The final discretization of the variational problem equation 2-6 





























































þï    2-8 
where A and B are complex matrices. Once the eigenvalues of equation 2-8 are 
solved, the eigen-wavelengths are calculated as λr = 2π/k0. 
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CHAPTER 3.    AN OPTOFLUIDIC METASURFACE FOR LATERAL FLOW-
THROUGH DETECTION OF BREAST CANCER BIOMARKER 
 Abstract 
The rapid growth of point-of-care tests demands for biosensors with high sensitivity 
and small size. This paper demonstrates an optofluidic metasurface that combines silicon-on-
insulator (SOI) nanophotonics and nanofluidics to realize a high-performance, lateral flow-
through biosensor. The metasurface is made of a periodic array of silicon nanoposts on an 
SOI substrate, and functionalized with specific receptor molecules. Bonding of a 
polydimethylsiloxane slab directly onto the surface results in an ultracompact biosensor, 
where analyte solutions are restricted to flow only in the space between the nanoposts. No 
flow exists above the nanoposts. This sensor design overcomes the issue with diffusion-
limited detection of many other biosensors. The lateral flow-through feature, in conjunction 
with high-Q resonance modes associated with optical bound states of the metasurface, offers 
an improved sensitivity to subtle molecule-bonding induced changes in refractive index. The 
device exhibits a resonance mode around 1550 nm wavelength and provides an index 
sensitivity of 720 nm/RIU. Biosensing is conducted to detect the epidermal growth factor 
receptor 2 (ErbB2), a protein biomarker for early-stage breast cancer screening, by 
monitoring resonance wavelength shifts in response to specific analyte-ligand binding events 
at the metasurface. The limit of detection of the device is 0.7 ng mL-1 for ErbB2. 
 Introduction 
Optical label-free biosensors can detect biomolecules based on their intrinsic physical 
properties, such as Raman scattering, refractive index, and second harmonic generation [105-
108]. In particular, many refractive index-based biosensors have been implemented to study 
analyte-ligand interactions without using labels [109-111]. In contrast to binding assays that 
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require fluorescent or enzymatic tags, label-free assays often eliminate the need for time-
consuming labeling processes and can monitor binding kinetics in real time [112-114]. 
Therefore, label-free biosensors are gaining increasing attention in the fields of life sciences, 
pharmaceutics, and clinic diagnosis [115-124]. Recently, optical resonators using surface 
plasmon resonance, photonic crystal, and whispering gallery mode [53, 125-129] have been 
extensively studied and exploited for label-free biosensors. Owing to their strong ability to 
confine resonating fields, these biosensors are sensitive to the presence of biomaterials 
immobilized in the close vicinity of their surfaces [130].   
While significant progress has been made to develop optical label-free biosensors, 
how to efficiently delivery samples to the sensor surface remains challenging. To address the 
issue with the mass transfer limitation, microfluidic systems have been developed and 
applied to label-free biosensors [131, 132]. To improve the integration between the sensing 
and fluidic elements, several optofluidic biosensors (e.g., liquid-core ring resonators [133] 
and anti-resonant reflecting optical waveguides [134]) have been used to facilitate the 
transport of analyte. Both the microfluidic and optofluidic approaches rely on a flow-over 
scheme, where liquid samples flow through a channel, during which the analytes diffuse 
from the sample stream onto the surface of the biosensor [135-138]. Recently, a vertical 
flow-through sensor design was implemented to label-free optical biosensing, where liquid 
samples flow through a horizontally placed, nanopatterned dielectric or metallic diaphragm 
with nanoholes that functions as both the sensing element and conduits [44, 46, 48, 139]. 
This sensor has enhanced the interaction between the sensing surface and analytes, thus 





Figure 3-1 (a) Schematic illustration of the optofluidic metasurface with a 2D array of SNPs. 
(b) SEM image of the fabricated SNPs. The inset shows a perspective view of the SNPs. (c) 
SEM images of the nanofluidic channel where the SNPs are sandwiched between the buried 
oxide of an SOI substrate and a capped PDMS cover. A sample can laterally flow through the 
SNP region and be captured by the recognition biomolecules onto the metasurface. 
This paper reports on a novel lateral flow-through biosensor, consisting of a 
metasurface with a two-dimensional (2D) periodic array of silicon nanoposts (SNPs), for the 
detection of cancer biomarker. The structure is manufactured in the thin top silicon layer of a 
silicon-on-insulator (SOI) substrate, coated with graphene oxide (GO) nanosheets, and 
biofunctionalized with specific antibody molecules. A polydimethylsiloxane (PDMS) slab 
with an inlet and an outlet is bonded to the top surface of the SNPs, thus restricting the flow 
of liquid analytes in between the PDMS and the buried oxide layer of the SOI substrate 
(Figure 3-1). It is worth noting that silicon or SOI-based metasurfaces have attracted 
increasing attention due to the flexibility in tuning of their optical properties [140-142], and 
the fabrication compatibility with complementary metal-oxide-semiconductor (CMOS) 
process. The high refractive index of silicon is favourable for light modulation [71, 143-146], 
e.g., to enhance optical fields. Our biosensor is featured with the lateral flow-through design 
for improved analyte-ligand interactions at the metasurface. Owing to a reduced diffusion 
length, the biosensor design will overcome the issue of mass transfer limit that occurs in 
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many existing label-free biosensors [147]. Therefore, the biosensor will have an improved 
sensitivity and a reduced assay time. In addition, the metasurface supports different optical 
resonance modes, such as the bound states in the continuum (BIC) mode, and leaky 
waveguide mode [97, 148, 149], to detect biomolecule absorptions. In this work, the guided 
mode resonance (GMR) mode, whose linewidth depends on the coupling angle, is utilized 
and exhibits a high sensitivity to a change in refractive index at the surface of SNPs. The 
sensor design emphasizes both analyte delivery and sensitivity. The key figure of merit of the 
device and its ability to detect cancer biomarkers are demonstrated.  
 Experimental section 
3.3.1 Fabrication of the optofluidic metasurface 
An SOI wafer is used to fabricate the SNPs. First, 200 nm-thick PMMA is coated 
onto the substrate at 2000 rpm for 45 sec. Subsequently, e-beam lithography is used to 
pattern the nanoholes array in the PMMA. Next, a 15 nm-thick Al2O3 layer is evaporated 
using electron-beam evaporation, and then patterned using lift-off process, to form a 
protection layer during the following deep reactive-ion etching of Si (Figure 3-1(b)). After 
the SNPs are formed, the Al2O3 layer is removed via wet chemical etching. The overall size 
of the device is 1 1 mm2. To enable laterally flowing liquid analytes through the SNP area, 
a 2 mm-thick PDMS slab with the pre-drilled inlet and outlet is bonded directly onto the top 
surface of the SNPs via oxygen plasma treatment. Figure 3-1(c) shows the formed 
nanofluidic channels embedded with the SNPs. 
3.3.2 Setup for optical reflection measurement 
A tunable laser (ANDO, AQ4321) is used as a light source providing a wavelength 
range from 1520 nm and 1620 nm with a central wavelength of 1570 nm. The light is 
collimated and incident onto the metasurface through a 50/50 beam splitter cube. The 
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biosensor is mounted on a rotation stage to adjust the angle of incidence. The reflection 
spectrum is measured in real time using an InGaAs photodetector synchronized through an 
oscilloscope. 
3.3.3 ErbB2 detection assay 
The biosensor is used to quantify a well-established breast cancer biomarker, ErbB2 
[150]. The biofunctionalization of the surface begins with introducing an intermediate layer 
of GO to the surface.  The GO layer allows enhancing the loading capability of anti-ErbB2 
molecules. In this step, the metasurface is treated with oxygen plasma for 50 sec to make the 
SNPs hydrophilic. Next, a well-dispersed solution of single-layer GO nanosheets (0.4 mg 
mL−1) is prepared in DI water, followed by thorough sonication for 1 hr. 50 μL of this 
solution is drop-cast onto the metasurface and then dried at room temperature (25 °C) for 2 
hr. 20 µL of PBS (pH = 7.4) solution containing anti-ErbB2 molecules (0.24 µM) is drop-
cast onto the GO-coated metasurface, followed by treating a mixed solution of EDC (1-ethyl-
3-(3-dimethylaminopropyl) carbodiimide hydrochloride, 0.2 M) and NHS (N-
hydroxysuccinimide, 0.05 M) at a 1:1 ratio [151]. The abundant oxygenated groups such as -
COOH and -CHO at GO are activated and utilized to make covalent binding with anti-ErbB2 
using the EDC-NHS coupling chemistry [150, 152]. To immobilize antibody molecules, the 
metasurface is kept in a humidity chamber for 12 hr, and then is washed with PBS to remove 
unbound antibody molecules. The resulting primary amine groups present at anti-ErbB2 bind 
with carboxyl groups at GO to form strong CH-NH amide bonds. Finally, 2.0 mg/mL of 
bovine serum albumin molecules is used to block non-specific sites of anti-ErbB2 on the 
metasurface.  
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 Results and Discussion 
3.4.1 Nanophotonic and nanofluidic simulations 
The SNP array (350 nm thickness) is designed on the top of a 3 µm-thick oxide layer 
to provide an optical resonance around 1550 nm wavelength. The silicon device layer is 
transparent around this wavelength and has a negligible extinction coefficient κ < 0.001 and a 
large refractive index n = 3.477. The geometric parameters of the SNPs include the array 
period (Λ), nanopost width (w), device layer thickness (tg), and duty cycle (η = w/Λ). The 
basic principle of the SNPs and corresponding optical characteristics have been discussed in 
our previous work [148]. The SNPs exhibit a BIC mode and a GMR mode, depending on the 
angle of incidence. As illustrated in Figure 3-1(a), the angle of incidence is defined in terms 
of a standard spherical coordinate system, with the polar angle θi being measured from the z-
axis. Because of the symmetry, the optical responses of the device are polarization-
independent when θi = 0.  
Rigorous coupled wave analysis (RCWA) is used to study optical resonances and 
evaluate their performances for detecting biomolecules (Figure 3-2). The details of the 
RCWA simulation method are described in Supplementary Information. Figure 3-2(a) 
presents the obtained photonic band diagram of the SNPs obtained by plotting the calculated 
reflection spectra as a function of θi. The wavelength and the incident angle change from 
1450 nm to 1650 nm, and from -15° to 15°, respectively. The region indicated by the black 
box (Figure 3-2(a)) contains a BIC mode, which appears at λr = 1536 nm and θi = 0. For the 
angles near the BIC mode, the strong reflection regions accommodate high-sensitivity 
resonance features. Figure 3-2(b) compares the simulated reflection spectra for θi = 0°, 1°, 2°, 
3°, and 4°. Since the characteristics of these two modes are similar to the transverse magnetic 
(TM)-polarized modes of the one-dimensional grating based metasurface demonstrated 
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previously [148], these modes can be named TM-like resonance modes. The obtained 
resonant linewidth decreases as the incidence angle approaches 0°. For example, the 
resonance linewidth at θi = 4° is found to be 30 nm, corresponding to a Q-factor of 52. In 
comparison, the Q-factor significantly increases to 900 when θi is reduced to 1°. The 
vanishing of the linewidth at θi = 0° implies the existence of BIC. 
 
Figure 3-2 Simulated optical characteristics of the 2D array of SNPs. a) Calculated reflection 
spectra over the wavelength range 1450 to 1650 nm, incident angle (θi) in the range of -15° 
to 15°. The region indicated by the black box contains a one BIC mode appears at λr = 1536 
nm at θi = 0. b) Calculated reflection spectra calculated for θi = 0°, 1°, 2°, 3°, 4°, and 5°. c) 
Near-field distributions of the Ex, Ez, and Hy components when λr = 1536 nm and θi = 1° 
The near-field distributions of the resonance mode in the xz-plane (Figure 3-1) are 
calculated using the RCWA method (Figure 3-2(c)). The distributions of the Ex, Ez, and Hy 
components are associated with the resonance (Q-factor = 900) at λr = 1536 nm and θi = 1°. 
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The colour scale represents the amplitudes of the electric and magnetic fields normalized to 
the amplitude of the incident field. As seen from the field distributions, the maximum field 
enhancement factor is as high as 300. The enhancement factor of the field intensity is 
calculated by averaging the electric field intensities within the sensor area (-Λ/2 < x < Λ/2 and 
0 < z < 350 nm). As a result, the averaged enhancement factor of the field strength (intensity 
or amplitude) is ~2.7 x 105. The distributions of the tangential components (Ex and Hy) 
appear asymmetric. The mode can be excited because of the asymmetric nature of the 
incident wave at θi = 1°. Figure 3-3(a) shows the normalized near-field distribution of Ex in 
the xy-plane at the center of SNPs (z = 175 nm). The plot shows five periods of the SNPs 
along both the x- and y- directions. 
 
Figure 3-3 (a) Calculated near-field distribution of Ex for five periods of the SNPs in the x-y 
plane. (b) Simulated distribution of flow rate when the liquid sample passes through the 
lateral flow-through biosensor. 
Fluid dynamics simulations are carried out to illustrate the flowing of an aqueous 
sample through the SNP area (see the details in Supplementary Information). Figure 3-3(b) 
displays the flow velocity distribution at the steady state. The sample solution is infused into 
the channel from the inlet (left boundary) and exits from the outlet (right boundary). The 
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analytes in the sample are not only brought to the sensor surface by the steams, but also 
diffuse to the sensor surface for the analyte-ligand interactions. To ensure high output 
signals, we chose the optical resonance, at which the localized optical field (Figure 3-3(a)) 
well overlaps with the region of analyte absorption. As shown in the following section, the 
biosensor is characterized at θi = 1° to obtain an optimized response. 
 
Figure 3-4 (a) Schematic diagram of the reflection measurement setup (b) Measured 
reflection spectra of the biosensor at five different angles of incidence. (c) Q-factor of the 
resonances as a function of θi. The data is fitted to demonstrate the exponential decrease of 
the Q-factor when θi. increased from 0° to 4° (d) Reflection spectra of the device with the 
sample surface immersed in DI water and solutions of ethanol-water mixtures. The spectra 
were measured at θi. = 1°. (e) Simulation (red line) and experiment (black dots) results of the 
resonance wavelength as a function of the refractive index. 
3.4.2 Characterization of metasurface 
3.4.2.1 Optical characterization 
The fabricated metasurface was characterized by measuring the reflectance from the 
metasurface using the setup shown in Figure 3-4(a). The reflection at a specific angle of 
incidence was measured in the near infrared range. A tunable laser, whose emission 
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wavelength ranging from 1520 nm to 1620 nm, was used as the excitation. The reflected 
laser beam was measured using an InGaAs photodetector.  
Figure 3-4(b) compares the measured reflection spectra when θi = 0°, 1°, 2°, 3°, and 
4°. The black curve represents the reflectance at θi = 0° where the BIC mode resides. 
Because the BIC mode is completely bound, there is no signature of resonance in the 
spectrum. When θi increases, the optical resonances appear as the narrowband dips in the 
reflection spectra. At θi = 1°, the BIC mode turns into a radiative resonance at λr = 1534 nm 
with a linewidth of  λr = 5.8 nm. Further increasing θi from 1° to 4° results in a significant 
increase of the resonance linewidth, while the resonance wavelength remains near λr = 
1537.2 nm. The measured spectra agree well with the simulated results (Figure 3-2(b)). To 
illustrate how to tune the resonance strength by changing θi, the Q-factor is plotted as a 
function of θi (Figure 3-4(c)). The Q-factor decreases exponentially from 270 to 57 with 
increasing θi from 1° to 4°. It is worth noting that the resonance features a flat angular 
dispersion, which can be exploited to realize refractive index-based sensing with a focused 
excitation. 
3.4.2.2 Refractometric sensing 
Figure 3-4(d) compares the measured reflection spectra when the metasurface is 
covered with different index solutions. The solutions are prepared by mixing deionized (DI) 
water and ethanol at different ratios of 1:2, 4:5, 1:1, 4:3, 2:1, 4:1, and 1:0, to produce the 
refractive indices of n = 1.340, 1.336, 1.334, 1.332, 1.329, 1.325, and 1.318, respectively. 
The black curve in Figure 3-4(d) shows the case when the channel is filled with DI water (n = 
1.318). The resonance dips are found to shift toward longer wavelengths with increasing the 
value of n. These reflection spectra are measured, all at θi = 1°. To calculate the index 
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sensitivity (Sb), the resonance wavelength of the device is plotted as a function of 
surrounding refractive index (Figure 3-4(e)). The resonance wavelengths are found by fitting 
the data in the vicinity of minimal reflection using a 2nd order polynomial function. The slope 
of the linear fit in Figure 3-4(e) is calculated as the index sensitivity Sb = Δλr/Δn = 720 
nm/RIU. 
 
Figure 3-5 (a) Schematics of the label-free assay and SEM of the SNPs with (left half) and 
without (right half) the GO coating. (b) Reflection spectra of the bare sensor, GO layer, and 
anti-ErbB2 antibody coating. Inset: Δλr after each step of the surface functionalization. (c) 
Reflection spectra measured in the present of ErbB2 at a series of concentrations ranging 
from 0.01 to 100nM. (d) Dose response curve for the detection of ErbB2 by plotting the 
resonance wavelength as a function of the ErbB2 concentration. (e) Reflection spectra 
measured for seven different combinations of ErbB2, ErbB3, and ErbB4 antigens. Inset: 
sensor outputs in the presence of interfering molecules. (f)Simulation (red) and experiment 
(black) results of the kinetic binding of ErbB2 and anti-ErbB2 antibody. 
3.4.3 Detection of breast cancer biomarker 
The SNP-based biosensor can be utilized to detect biomolecules, such as DNA, 
protein, or small molecules, in real time. As an example, the device is used to quantify a 
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well-established breast cancer biomarker, ErbB2. As a label-free technology, the SNP-based 
biosensor measures the refractive index change caused by the immobilization of the ErbB2 
molecules. The target ErbB2 molecules are captured by the anti-ErbB2 antibodies on the 
sensor surface. The details of this label-free assay are described in the Experimental section. 
Figure 3-5(a) summarizes the major assay steps, including subsequent deposition of GO, 
anti-ErbB2 antibody, and blocker, and the detection of ErbB2 antigen. The SEM image in 
Figure 3-5(a) show the SNPs with and without the GO coating. The thickness of the GO 
layer is about 30 nm. Figure 3-5(b) presents the measured reflection spectra of the device 
when the SNPs is bared (black), coated with a GO layer (red), and functionalized with anti-
ErbB2 molecules. 
Figure 3-5(c) shows the reflectance spectra recorded when the samples containing 
ErbB2 are injected into the nanofluidic channel. The sample solution is prepared by dissolved 
ErbB2 in a phosphate-buffered saline (PBS; pH = 7.4) solution at six concentrations (0.01 
nM, 0.1 nM, 0.5nM, 1 nM, 10 nM, and 100nM). As the concentration of ErbB2 increases, the 
resonance dip in the reflection spectrum red shifts to longer wavelengths. The total shift of 
the resonance wavelength is approximately 6 nm when the ErbB2 concentration increases 
from 0.01 nM to 100 nM. The dose response for the detection of ErbB2 biomarker is shown 
in Figure 3-5(d). The experiment with a specific ErbB2 concentration repeats five times and 
the error bars represent the standard deviation of resonance wavelength for each 
concentration. The sensitivity of optical sensors can be estimated using Ss = Δλr /∆c, where 
∆c is the corresponding concentration difference. The SNP-based biosensor exhibits a 
sensitivity of 2 nm/nM for ErbB2. 
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Table 1 compares the key performance of this biosensor with some recently reported 
label-free biosensors for the detection of ErbB2 [112, 113, 153-156]. With regards to the 
sensitivity, the SNP-based biosensor outperforms the reported ring resonator biosensor (Ss = 
0.12 nm/nM) and distributed feedback grating (Ss = 2x10
-3 nm/nM) biosensor [153, 154]. The 
limit of detection (LOD) of the SNP-based biosensor is found to be 0.7 ng mL-1 using the 3s 
criterion (expressed in concentration units), where s represents the standard deviation of five-
time measurements for the PBS solution. Compared to the other two optical biosensors, the 
SNP-based biosensor provides a lower LOD. In addition to the high refractive index 
sensitivity of the metasurface, the lateral flow-through design contributes significantly to the 
increased sensitivity and the lowered LOD by offering a useful platform for realizing the 
syngeneic interaction between minute amounts of ErbB2 proteins available in the sample and 
the capture molecules on the surface of SNPs. Although some of the reported electrochemical 
biosensors exhibit lower LOD values, our device presents a wider dynamic range. 
Table 1 Performance comparison of the lateral flow-through biosensor with other devices for 













resonance  2 nm nM




mode 0.12 nm nM
-1 0.14 – 3.45 13  
1D distributed feedback 
grating 
1st-order diffraction 
mode 2 × 10
-3
 nm nM




Electrochemical 15 × 10-3 µA nM-1 1x10-6 – 1.381 37  
Sandwich 
magnetoimmunosensor 
Electrochemical 1.4 × 10-4 μA nM-1 1.4x10-3– 0.4 0.026  
Capacitance based 
aptasensor 
Electrochemical 1.7 × 10-3 pF nM-1 2.7 x10-3 – 2.7 x10-2 0.2  
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To study the selectivity of the label-free biomarker detection assay, samples 
containing ErbB2, ErbB3, and ErbB4 antigens were measured using the anti-ErbB2 
antibody-coated metasurface. These antigens belong to the ErbB receptor tyrosine kinase 
family, but the ErbB3 and ErbB4 antigens are nonspecific to the anti-ErbB2 antibody[152]. 
Figure 3-5(e) shows the measured reflection spectra of seven samples with different 
combinations of ErbB2, ErbB3, and ErbB4 antigens (1nM). The inset of Figure 3-5(e) 
summarizes the resonance wavelength measured for these samples. The samples with the 
ErbB2 antigen and interfering molecules result in a resonance wavelength shift of 6 nm. In 
contrast, the samples without ErbB2 molecules show very small shift (<1 nm) of the 
resonance wavelength. The results indicate that the SNP-based biosensor is selective to the 
target ErbB2 antigen when the SNPs is functionalized using the anti-ErbB2 antibody.  As a 
label-free detection method, the biosensor can monitor the analyte-ligand binding process in 
real time. In this experiment, the reflection spectra were recorded when the ErbB2 bound to 
the ErbB2 antibody-coated sensor surface. Figure 3-5(f) shows the temporal change of the 
resonance wavelength when the ErbB2 sample (0.01 nM) passes through at a flow rate of 0.3 
µL/min. The simulated and experimental results for ErbB2 and anti-ErbB2 binding are 
compared in Figure 3-5(f). The error bars show the standard deviation of resonance 
wavelength shift for three replicated tests.  The simulation of the binding process is 
performed using a finite element method (FEM) model that includes the fluid dynamics of 
the sample inside the nanofluidic channel, the diffusion of analyte from the solution to the 
sensor surface, and the surface reaction process. The details of the simulation are described in 
the Experiment section. The binding of the ErbB2 to the surface results in an increase of λr 
around 6 nm. 
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 Conclusion 
In summary, this paper demonstrates a label-free, lateral flow-through biosensor that 
combines both biomolecule detection and sample delivery functions using the SOI-based 
metasurface. The SNPs provide numerous nanoscale flow channels to facilitate rapid delivery 
of analyte to the sensor surface. The device utilizes the GMR mode of the metasurface and 
operates in the telecom optical wavelength band. The linewidth of the resonance is tuned by 
changing the angle of incidence. The biosensor exhibits the refractive index sensitivity of 720 
nm/RIU. The biosensor is studied for its ability to detect the ErbB2 breast cancer biomarker. 
Because the SNP-based biosensor can be fabricated using the CMOS-compatible process, the 
device is amendable to integration with a wide variety of lab-on-a-chip components. We 
envision that the biosensor will enable rapid and quantitative analysis in point-of-care 
applications, such as disease diagnosis, drug test, and pathogen detection.  
 Supplementary information 
3.6.1 Electromagnetic modeling 
Optical simulations are carried out using a commercial Rigorous coupled wave 
analysis (RCWA) software package (DiffractMOD, Synopsis). The simulation is set up to 
analyze a unit volume of the metasurface, where periodic boundary conditions are applied to 
define the calculation domain. Ten harmonics are used to expand the permittivity and fields 
along the x-direction. The dispersive and complex refractive indices of crystalline silicon, 
n(λ) = nsi(λ) + iκsi(λ), where nsi = 3.486 + i0.001 at λ = 1550 nm. The reflection and 
transmission spectra are calculated in the near-infrared wavelength range. 
3.6.2 Fluid dynamic simulation 
Finite element method (FEM) is used to simulate how molecules in the bulk solution 
transported to the sensor surface and react with the capture molecules. This dynamic process 
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includes laminar flow transport, diffusion of diluted specious, and surface reaction. 
Stationary laminar flow with no-slip boundary condition and periodic flow condition are used 
in the model. The Navier-Stokes equation governs the motion of fluidics and can be seen as 




+ ?⃗⃗? ⋅ 𝜵?⃗⃗? ) = −𝜵𝒑 + 𝜵 ⋅ (𝝁(𝜵?⃗⃗? + (𝜵?⃗⃗? )𝑻) −
𝟐
𝟑
𝝁(𝜵 ⋅ ?⃗⃗? )𝑰) + 𝑭  3-1 
where ?⃗? is the fluid velocity, 𝑝is the fluid pressure, 𝜌is the fluid density, and 𝜇is the 
fluid dynamic viscosity. At the sensor surface, the kinetic sensor response as analyte 
molecules in the bulk solution is transported and diffused to bind with the capture molecules. 
The governing differential equation used for the analyte concentration in the bulk solution is 
the convection-diffusion equation listed below as 
𝜕𝑐𝐴
𝜕𝑡
+ 𝛻 ⋅ (−𝐷𝛻𝑐𝐴 + 𝑐?⃗? ) = 0      3-2 
where 𝑐𝐴, 𝐷, and ?⃗?  are the bulk analyte concentration, the bulk diffusion constant, 
and fluid flow velocity vector, respectively. At the sensor surface, the boundary condition is 
represented by coupling of the rate of reaction at the surface with the flux of the reacting 
species and the concentration of the adsorbed species and bulk species as 
𝑁 = 𝑘𝑎𝑐𝐴(𝜃0 − 𝑐𝐴𝐵) − 𝑘𝑑𝑐𝐴𝐵    3-3 
where N is the adsorption and desorption of analyte at the reactive surfaces give rise 
to a net flux represented as ?⃗? ⋅ (−𝐷𝛻𝑐𝐴 + 𝑐?⃗? ). At the inlet of the channel where analyte 
solution is introduced, the boundary condition used here is 𝑐 = 𝑐0. 
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CHAPTER 4.    RAPID DIFFERENTIATION OF HOST AND PARASITIC 
EXOSOME VESICLES USING MICROFLUIDIC PHOTONIC CRYSTAL 
BIOSENSOR 
 Abstract 
Parasite extracellular vesicles (EVs) are potential biomarkers that could be exploited 
for the diagnosis of infectious disease. This paper reports a rapid bioassay to discriminate 
parasite and host EVs. The EV detection assay utilizes a label-free photonic crystal (PC) 
biosensor to detect the EVs using a host-specific transmembrane protein (CD63), which is 
present on EV secreted by host cells (modeled by murine macrophage cell line J774A.1) but 
is not expressed on EV secreted by parasitic nematodes such as the gastrointestinal nematode 
Ascaris suum. The surface of PC is functionalized to recognize CD63, and is sensitive to the 
changes in refractive index caused by the immobilization of EVs. The biosensor 
demonstrates a detection limit of 2.18×109 EVs/mL and a capability to characterize the 
affinity constants of antibody-host EV bindings. The discrimination of murine host EVs from 
parasite EVs indicates the capability of the sensor to differentiate EVs from different origins. 
The label-free, rapid EV assay could be used to detection parasite infection and facilitate the 
exosome-based clinic diagnosis and exosome research. 
 Introduction 
Recently, membranous extracellular vesicles (EVs), including nanoscale exosomes 
and other vesicles derived from cancer cells, have also been found in the blood of cancer 
patients[157-159]. These membrane-bound phospholipid nanovesicles are actively secreted 
by both prokaryotic and eukaryotic cells, including mammalian cells and pathogens like 
parasitic helminths[160-162]. EVs secreted from helminths contain effector molecules such 
as functional proteins and small RNAs, and as with other systems. There is emerging 
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evidence demonstrating that EVs released from helminths could traffic within the host’s body 
fluid and interact with the immune system to modulate the host immune response[163-165]. 
EVs have also been considered as an important mediator of the cell to cell communication; 
because of the membrane-based structure, they are more stable than proteins and nucleotides 
biomarkers that are secreted alone, which arouses the potential of using EVs to diagnose 
infectious diseases and other human diseases like cancer.  
Rapid, multiplexed exosome analysis can be used to detect minute amounts of various 
biomarkers for diseases that are currently difficult to diagnose and monitor such as cancer, 
infectious, autoimmune and degenerative diseases. Fluorescence-based approaches, such as 
bead-based assays, have the multiplexing capability and high sensitivity but require excessive 
volumes of serum[166, 167]. Compare to conventional methods based on immunoblotting or 
enzyme-linked immunosorbent assay (ELISA) assays[168-171], the PC-based label-free 
assay eliminates the labeling step. The outputs of PC-based devices can be measured in real 
time and the assay time can be significant reduced[25, 109, 172-174]. Recently, several 
biosensors have been reported for the analysis of exosomes[111, 175-180], using surface 
plasmonic resonance[111], nuclear magnetic resonance[179], and electrochemical 
aptasensor[180].  
The paper reports the discrimination of EVs derived from murine macrophages and 
parasites using a photonic crystal (PC) biosensor. The PC biosensor, consisting of a sub-
wavelength grating, is essentially a narrowband optical reflector that reflects a particular 
wavelength of a broadband excitation. The capture of EVs on the biosensor increases the 
refractive index on the sensor surface and results in a change in the light reflectance of the 
PC. Using the PC biosensor, we have developed a label-free binding assay to detect EVs 
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according to their membrane-specific proteins, and distinguish EVs secreted by a murine 
macrophage cell line (J774A.1) and a parasitic nematode (Ascaris suum). In addition, the 
developed assay can measure the binding of EV to its ligand in real time, thus enabling 
characterization of the EV-antibody binding affinity. 
 
Figure 4-1 (a) Schematic diagram of the extraction of EVs from culture media. The EVs 
samples are centrifuged and re-suspended before being flowed into the microfluidic chip. (b) 
Illustration of the microfluidic PC biosensor chip. Four channels are designed for the host, 
parasitic, positive, and negative reference samples respectively. (c) Schematic structure of the 
PC grating and the label-free detection mechanism. The PC surface functionalized with the 
antibody (black box) exhibits resonant reflection (black curve in the reflection spectra). The 
binding of EVs to the antibody (red box) shift the narrowband reflection by a spectral shift of 
Δλr. 
 Experimental section 
4.3.1 Preparation of host and parasite EV samples 
The host and parasite EVs were isolated from spent murine macrophage and parasitic 
nematode culture media, respectively. Murine macrophage cell line (J774A.1) were cultured 
in DMEM containing 10% FBS (Thermo Fisher Scientific, Waltham, MA), 100 Units of 
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penicillin (Thermo Fisher Scientific, Waltham, MA), 100 g/ml of streptomycin (Thermo 
Fisher Scientific, Waltham, MA), and 2 mM L-glutamine (Sigma-Aldrich, St. Louis, MO). 
Female adult Ascaris suum were collected from a local abattoir and maintained in Ascaris 
Ringer’s solution at 37C. Culture media was collected after 24 hr  and filtered using 0.22-
µm syringe filters (Millipore Sigma, Burlington, MA) to remove debris then EV were 
purified by differential centrifugation as previously described[161]; The EV pellets were re-
suspended in 100-L PBS solution and stored in a -80 C freezer. The presence of EVs in 
these isolated preparations was confirmed using Nanoparticle Tracking Analysis (NanoSight 
LM10, Malvern Instruments, Malvern, UK). Figure 4-1(a) illustrates the process of preparing 
membranous extracellular vesicles, including nanoscale exosomes. The details of the 
materials and supplies are given in the supporting information. 
4.3.2 PC biosensors embedded in microfluidic channels 
The PC biosensor used in this study consists of a one-dimensional (1D) grating 
substrate, which is coated with a high-refractive-index thin film as shown in Figure 4-1(b). 
The high-refractive-index thin film acts as a light confinement layer and supports the 
resonance modes that are evanescently confined to the PC surface. The grating modulation 
allows the phase matching of excitation light to the PC resonances and results in the 
narrowband reflection[181].  
The PC biosensors can detect chemicals and biomolecules via the biochemical 
interactions occurred on their surfaces. The adsorbed molecules on the sensor surface cause a 
change in the effective refractive index, which shifts the peak in the reflectance. The amount 
of spectral shift is proportional to the concentration of the target molecule as shown in Figure 
4-1(c). Since its early demonstration[182], the PC biosensor has gained significant attentions 
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and been utilized for the analysis of various biomaterials, such as pathogens, DNA, proteins, 
enzymes, cells, and toxins[182-185].  
The details of the PC fabrication and readout instrument are described in the 
supporting information. In brief, the sub-micron grating structure of the PC biosensor was 
fabricated inexpensively using the nano-replica molding method[186]. The molding silicon 
stamp (LightSmyth Technologies, Eugene, OR) carries a 1D grating with a period of 555.5 
nm. The grating pattern was replicated on the surface of glass coverslip using UV curable 
epoxy (Norland Products, Cranbury, NJ). A titanium-oxide (TiO2) was deposited on the 
replicated grating. To facilitate the detection of EVs, the fabricated PC structures were 
incorporated with microfluidic channels as shown in Figure 4-1(b). Four microfluidics 
channels were created, and each channel contained the PC grating (0.5 mm × 4 mm) in the 
middle. A broadband white light (Ocean Optics, Largo, FL) was used as the excitation and 
the light reflected off the PC grating was analyzed using a compact spectrometer (Ocean 
Optics, Largo, FL)[187]. The measured reflection spectra were analyzed to find the peak 
reflection wavelength (λr). The optical readout system was positioned below the microfluidic 
chip and aligned to the PC regions one at a time.   
Before the sensors are used for the EV analysis, we functionalized the sensor surface 
using the EV specific antibody. The PC biosensor with the antibody coating is illustrated in 
the Figure 4-1(b). When the EVs bind to the antibodies (red box in Figure 4-1(b)), the 
reflection peak wavelength will redshift (Figure 4-1(c)) and the amount of wavelength shift 
(Δλr) will correspond to the concentration of EVs. 
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Figure 4-2 (a) Flow chart for the functionalization of the PC biosensor. (b) Measured 
wavelength shift as a function of time during the functionalization process. The black, red, 
blue, and green portions of the curve denote the PVA, GA, antibody, and BSA coating. (c) 
Resonant wavelength shift of the sensor after each step of the real-time measurement shown 
in (b). 
 Results and discussion 
4.4.1 Surface functionalization for the PC biosensor 
Before the PC biosensor was used for the analysis of EVs, we functionalized the 
sensor surface using a four-step process[188]. Figure 4-2(a) summarizes the major steps of 
the functionalization process (see details in the supporting information). During the process, 
the resonant wavelength shift was recorded every two seconds and plotted in Figure 4-2(b). 
The initial step (black line in Figure 4-2(b)) was the coating of a porous polymer layer 
(Polyvinylamine, PVA) that can provide a high-density amine group. The PVA coating 
process lasted 5 hours and was followed by a wash using DI water. Then, a bifunctional 
linker, glutaraldehyde (GA), was pumped into the channels. After 1.5 hours incubation (red 
line in Figure 4-2(b)), the channels were washed using DI water. Before the solution of 
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capture antibody, anti-CD63, was introduced into the channels, the buffer solution was 
changed to the PBS (pH = 7.4) and the resonance wavelength was measured. The anti-CD63 
solution (0.1 mg/mL) was incubated inside the channels for overnight and then washed using 
the PBS solution. The final step was using the bovine serum albumin (BSA) solution (0.5% 
in 0.85% sodium chloride) to block the unoccupied aldehyde groups on the GA layer for four 
hours. The results of the anti-CD63 coating and BSA blocking are shown in Figure 4-2(b) as 
the blue and green portions, respectively. After the BSA blocking, the biosensors wereready 
for the analysis of EVs. The 4-steps functionalization process took less than 20 hours, which 
can be future optimized.  
Figure 4-2(c) summarizes the resonant wavelength shift after each step of the process 
based on the real-time measurement shown in Figure 4-2(b). The first two columns in Figure 
4-2(c) represent the sensor signals after PVA and GA coatings. The wavelength shifts are 
approximately Δλr = 0.15 nm and 0.2 nm, respectively. The third column shows ~0.4 nm 
wavelength shift owing to the change of buffer from DI water to PBS. The absorption of the 
anti-CD63 and BSA blocker results in Δλr = ~0.5 nm and ~0.25 nm, respectively. The 
measured resonance wavelength shift for each step was calculated based on the previous step. 
In each column, the error bar was the standard deviation calculated using nine independent 
measurements from nine PC sensors. 
4.4.2 Detection of EVs secreted by murine macrophages 
As a label-free detection approach, the PC biosensor can monitor the analyte-ligand 
binding process by recording the sensor output in real time. The host EVs were extracted 
from the murine macrophage cell culture and prepared to obtain a concentration of 2×1011 
EVs/mL. Figure 4-3(a) shows the sensor output over time when the host and parasite EV 
solution was flowed through the microfluidic channel at a flow rate 30 µL/min. The 
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reflection spectrum was measured every two seconds and the Δλr values were calculated. 
After 180 minutes, the ligand-analyte binding reached an equilibrium. Then, we washed the 
channels using PBS to remove the unbounded EVs and let the binding process enter the 
dissociate phase. After the PBS wash, the EVs binding results in a Δλr of approximately 
0.7nm. The positive and negative reference experiments were tested using the biosensor. For 
the positive reference experiment, the GA-coated PC biosensors were used to capture EVs 
without targeting a specific membrane protein. The positive reference experiment exhibited 
an output of Δλr = 1.8 nm. In contrast, the negative reference experiments were carried out on 
the BSA-blocked PC surface without anti-CD63 antibody. The sensor output is nearly zero 
for the negative reference experiment. The details of the reference experimental processes are 
given in supporting information. As shown in the sensorgrams in Fig 3(a), the label-free 
signals still slowly increase at the saturation region. According to the pervious study[189] on 
the label-free sensorgrams, our dynamic response curves in Figure 4-3(a) include both the 
binding reaction and the EV diffusion processes. To identify the limit of detection (LOD), we 
measured host EV samples at a dilution serial of six concentrations ranging from 2×109 
EVs/mL to 2×1011 EVs/mL. The samples were diluted consecutively by a factor of two in 
PBS. Figure 4-3(b) shows the dose-response curve, Δλr versus EV concentration, in 
logarithmic scale. At 2 × 1011 EVs/mL, the sensor output starts to saturate with Δλr = 0.7 nm. 
The dose-response data was fitted with a sigmoidal curve (the red line in Figure 4-3(b)) with 
a reduced chi-squared (R2) value of 0.854. The error bar in the dose-response curve 
represents the standard deviation (σ) of Δλr measured using nine different PC biosensors. The 
LOD of this sensor was calculated by the summation of the noise signal arising from the 
negative reference and the 3σ of the EV sample at the lowest concentration. The LOD is 
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found to be 2.18×109 EVs/mL that falls in the range of the clinically relevant concentration of 
EVs from 1×108 to 3×1012 exosomes/mL[190-192]. Therefore, the presented sensor will find 
it useful in applications of clinic diagnosis. The value of the equilibrium dissociation 
constant, KD, can be determined by the ligand half maximal effective concentration (EC50) 
based on the Michaelis-Menten equation[193, 194]. In our case, based on the obtained dose 
response in Figure 4-3(b), the value of KD was found to be EC50 = 2.36×10
10 EVs/mL using 
the fitted curve (see red dashed curve). 
 
Figure 4-3 (a) Kinetic binding of anti-CD63 with host and parasite EVs at the concentration 
of c =2×1011 EVs/mL. (b) Measured resonance wavelength shifts as a function of 6 different 
concentrations of EVs from 2×109 EVs/mL to 2×1011 EVs/mL. The experiment data is fitted 
(red dash curve) and the EC50 is determined by the blue dash lines. (c) Box plot of the Δλr for 
host and parasite EVs at 2×1011 EVs/mL in comparison to the results of positive and negative 
references. (d) SEM images of the host and parasite EVs immobilized on the PC surface at 
the concentrations of 2×1011 EVs/mL. Scale bar: 1 μm. 
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4.4.3 Differentiation of host and parasite EVs 
In the present study, the surface protein chosen to distinguish the EVs that are 
released by the host and the helminth is CD63, which is a well-established exosome 
marker[195]. Recent studies showed that CD63 presents on the surface of other vesicles 
too[195]. However, ongoing proteomic analysis by our group demonstrates that the EVs 
released from Ascaris suum do not contain the homologue of CD63, and that CD63 
homologues are not found in the Ascaris genome. The absence of these proteins strongly 
suggests that the composition of Ascaris suum EVs is different to that from the host cells. 
Indeed, recent analysis by our group suggests parasite-derived EVs have widespread species- 
and stage-specific protein composition[196]. Such differences in surface protein expression 
allows us to develop the EV differentiation assay. 
The box plot in Figure 4-3(c) shows the resonance wavelength shift for host and 
parasite exosome detection with the positive reference and negative reference. Bars indicate 
mean and 25th and 75th percentiles and lines indicate mean±1.5 times the interquartile range. 
From the box plot in Figure 4-3(c), the exosome vesicles from the host with a concentration 
of 2×1011 EVs/mL have around 0.7 nm resonance wavelength shift, which this value between 
the positive reference and negative reference experiment. The detection of the parasite EVs 
using the anti-CD63 antibody-coated PC sensor generated a nearly zero output. For the 
positive reference experiment, the EVs were captured regardless of the type of 
transmembrane proteins. The positive reference experiment shows a signal of 1.6 nm shift. 
Figure 4-3(c) demonstrate the capability to discriminate EVs from host cells and parasites. 
Compared to the host EVs, the parasite EVs do not carry CD63 antigens. The details of the 
PC sensor outputs of the parasite EVs, its positive reference, and negative reference 
experiments are shown in supporting documentation. The reference experiment can be used 
59 
to estimate the noise level of our sensor system. As shown in Figure 4-3(c), the overall 
system noise level is 0.03 nm, which can be calculated using the standard deviation of the 
negative reference test. The label-free assay can be utilized to diagnose infectious disease 
using EVs. Figure 4-3(d) shows the scanning electron microscope (SEM) image of the host 
EVs and parasite EVs immobilized on the PC surface at the concentrations of 2×1011 
EVs/mL. The average size of the EVs is approximately 100 nm. The PC-based label-free 
assay can be used for the rapid differentiation of exosome vesicles from host and parasite in 2 
hours. 
 Conclusion 
In summary, we have demonstrated the use of the PC biosensor for rapid and specific 
discrimination of EVs extracted from the culture media; furthermore, incorporation of the PC 
biosensor into microfluidic channels allows for parallel quantification of EVs from different 
sources. The advantages of the PC-based label-free assay include the low-cost and disposable 
sensor, short assay time, and improved spectral sensitivity. The PC biosensors are less 
expensive than the gold coated nanohole array used in work of H. Im et al.22 Compared with 
the SPR device, the narrower linewidth of the PC resonance enables the detection of EVs 
without using a signal enhancer. Simplicity of the PC-based EV assay would permit detection 
in non-laboratory settings, thus eliminating the use of additional label reagents. The obtained 
LOD for pre-cleaned EV samples is 2.18×109 EVs/mL. We expect that the detection limit 
may be further improved through the use of nanoparticles to enhance the sensor signal or by 
optimizing the PC structure to achieve resonances with reduced spectral 
linewidth[197],[148]. This work focused on a single exosomal protein marker but EVs 
membrane carries more than one markers. The analysis of multiple exosomal markers 
simultaneously will allow tracking the origin of EVs in complex samples such as blood. Our 
60 
future work will utilize the PC-based microarray technology[198] to generate a profile of 
surface protein markers on the target EVs. With minimal sample processing, simple assay, 
and high throughput, the implementation of PC biosensor will enable EV analysis in point-
of-care applications, such as diagnosis of parasite infections in near future. 
 Supporting information 
4.6.1 Materials and supplies 
Phosphate buffered saline (PBS 10×) and bovine serum albumin (BSA) were 
purchased from Fisher Scientific (Hampton, NH, USA). Polyvinylamine (PVA, Lupamin® 
9095) was purchased from BASF (Ludwigshafen, Germany). Glutaraldehyde (GA) solution 
(25% in H2O) was purchased from Sigma-Aldrich (St. Louis, MO, USA). Anti-CD63 
Antibody, clone RFAC4 is an antibody against CD63 and was purchased from Merck 
Millipore (Billerica, MA, USA). The host and parasite exosome vesicles (EVs) were isolated 
from spent murine macrophage and parasitic nematode culture media, respectively. Murine 
macrophage cell line (J774A.1) was cultured in DMEM containing 10% FBS, 100 units of 
penicillin, 100 g/mL of streptomycin, and 2 mM L-glutamine, which were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Syringe filters were purchase from MilliporeSigma 
(Burlington, MA, USA). 
4.6.2 Fabrication of photonic crystal (PC) and microfluidic channel 
A nano-replica molding technique was used to fabricate the PC structure[186], where a 
nanopatterned silicon stamp was purchased from LightSmyth Technologies (SNS-C18-
2009). This silicon mold carriers a linear grating or PC structure (period: 555.5 nm; depth: 
140 nm; ridge width: 340 nm). To transfer the PC structure onto the surface of polymer, a 
drop of liquid ultraviolet (UV)-curable polymer (NOA-88, Norland Products, Cranbury, NJ) 
was injected into an air gap formed between the mold and a glass coverslip (24 mm × 60 mm 
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× 0.1 mm; Fisher Scientific, Hampton, NH). Subsequently, the UV curable polymer was 
exposed to UV light at room temperature. As a result, the UV-curable polymer was 
polymerized and the PC was formed at the surface of polymer. After curing, the silicon mold 
was separated from the replica. The separation was facilitated by pretreatment of the mold 
with an anti-adhesion saline (Trichloro(1H,1H,2H,2H-perfluorooctyl) silane, Sigma-
Aldrich). Next, a TiO2 layer was deposited over the PC by electron beam evaporation (BJD-
1800, Temescal). The thickness and refractive index of the TiO2 layer were measured using a 
spectral reflectometer (F20, Filmetrics). To tune the resonance wavelength near 850 nm, the 
thickness of the TiO2 layer was chosen as 150 nm. The refractive index of the deposited TiO2 
was 2.2. Figure 4-4(a) shows the fabrication process of the polymer-based PC sensor 
structure formed on the glass slide. 
To form microfluidic channels for the PC sensor (Figure 4-4(b)), a slit was first cut 
through a 100 µm-thick parafilm sheet (Parafilm® M) by a laser engraving cutting machine. 
Subsequently, the engraved parafilm was placed between the glass slide with the PC structure 
and a new glass slide with pre-drilled holes. Finally, the three layers were bonded using a hot 
press under ~15 kg pressure at 85°C. 
 
Figure 4-4 Schematics of the fabrication processes for (a) manufacturing of a PC surface and 
(b) integration of a microfluidic channel with the PC surface. 
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4.6.3 Sensor surface functionalization 
The microfluidic channel with the embedded PC was filled with a diluted PVA 
solution (1:50 volume ratio in water) and soaked for 12 h, followed by washing with 
deionized (DI) water for five times. The shift of resonance wavelength was measured. The 
PVA was attached to the PC surface via non-covalent interactions, providing high-density 
amine groups. Next, the microfluidic channel was filled with GA solution (25% in water; 
Sigma-Aldrich) and incubated for 4 h, followed by five times washing with DI water. The 
GA treatment enabled subsequent covalent attachment of antibody molecules with exposed 
amine moieties. The GA-induced wavelength resonance shift was measured relative to the 
PVA coating. Because the binding of antibody to exosome vesicles occur at pH = 7.4, the DI 
water in the channel was replaced by PBS. The wavelength resonance shift to the solution 
replacement was also monitored. 
4.6.4 Detection setup 
The reflection spectra of the sensor were obtained using the setup shown in Figure 
4-5. An incident light came from a broadband white light source (HL-2000, Ocean Optics) 
and coupled into a bifurcated fiber. A linear polarizer was placed between a collimator and 
the sensor so that only the TM-polarized guided mode resonance (GMR) mode was 
measured. A ~3 mm-diameter spot in the sensing area was illuminated at normal incidence. 
The reflected light from the sensor was collected using the bifurcated fiber connected to a 
spectrometer (USB 2000, Ocean Optics). 
When we process the data, we collect the lowest point with ±10 points to do the 
polynomial fitting. Using this method, we can measure the resonance shift as low as 0.05nm. 
We will clarify this in the supporting information. 
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Figure 4-5 Schematic of the optical measurement setup for the sensor 
4.6.5 Label-free assay protocol for EVs 
The response of the sensor to the EVs extracted from the host cells (J774A.1) is 
shown in Figure 4-6(a). The results of corresponding positive and negative control 
experiments are shown in Figure 4-6(b) and Figure 4-6(c), respectively. The first three 
columns (from left to right) in each panel of Figure 4-6 show the responses of the sensor to 
the sequential surface treatments with PVA and GA, and surface washing using DI water, 
and then PBS buffer. The fourth and fifth columns in Figure 4-6(a) show ~0.5 nm and ~0.25 
nm resonance wavelength shifts in response to the immobilization of anti-CD63 antibody and 
BSA blocker, respectively. The sixth column in Figure 4-6(a) shows ~0.7 nm resonance 
wavelength shift due to the presence of EVs secreted from the host cells. The concentration 
of the host EVs in Figure 4-6 was 2×1011 EVs/mL.  
As a positive control, the sensor surface could capture almost all host EVs because it 
was not functionalized with specific antibody molecules. In this experiment, the sensor 
surface was treated sequentially using PVA and GA and then washed using PBS buffer. 
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Because of nonspecific binding, the host EVs were captured onto the GA-treated sensor 
surface. The last column (from left to right) in Figure 4-6(b) shows a 1.6 nm resonance 
wavelength shift due to the nonspecific binding of the host EVs onto the sensor surface. 
During a negative control experiment, the sensor surface was first functionalized 
using PVA and GA, and washed using PBS buffer, and then treated with BSA to block the 
aldehyde groups on the GA layer. Therefore, when CD63 antibody molecules and EVs came 
to the sensor surface, no responses were observed (Figure 4-6(c)). 
 
Figure 4-6 Resonance wavelength shifts of the sensor during the assays for (a) the EVs from 
the host cell (J774A.1) culture, (b) a positive control, and (c) a negative control. 
The responses of the sensor to the EVs secreted from parasitic nematodes (Ascaris 
suum) are presented in Figure 4-7(a). The results of corresponding positive and negative 
control experiments are shown in Figure 4-7(b) and Figure 4-7(c), respectively. Compared to 
the host EVs, the parasite EVs do not carry CD63 antigen molecules. As a result, almost no 
resonance wavelength shift was observed from the sensor responding to the presence of the 
parasite EVs (Figure 4-7(a)). In the positive control experiment, because the EVs could be 
captured regardless of the type of transmembrane proteins, there exhibited a 1.6 nm 
resonance wavelength shift.  
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Figure 4-7 Resonance wavelength shifts of the sensor during the assays for (a) the EVs 
extracted from the parasites (Ascaris suum), (b) a positive control, and (c) a negative control. 
The results presented in Figure 4-6 and Figure 4-7 demonstrate the ability of the 
sensor to discriminate the EVs secreted from host cells and parasites. Figure 4-8 shows the 
scanning electron microscopic (SEM) images of the sensor surfaces with the host EVs 
(concentration: 2 × 1011 EVs/mL; Figure 4-8(a)), after the positive control experiment 
(Figure 4-8(b)), and after the negative control experiment (Figure 4-8(c)). These SEM photos 
were taken after the sensor surface was washed using DI water for three times. Then the 
photonic crystal biosensor was removed from microfluidics channel, coated with a discharge 
metal film, and measured using the SEM. The results indicate that the non-specific binding of 
the positive control results in the highest density of the host EVs presented on the sensor 
surface, while the BSA blockers led to the lowest density (almost zero) of the host EVs. 
 
Figure 4-8 SEM images of the host EVs captured by the sensor surface: (a) the original EVs with a 
concentration of 2×10
11
 EVs/mL, (b) after the positive control, and (c) after the negative control. 
Scale bars represent 1 µm. 
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4.6.6 Kinetic binding curve 
Figure 4-9 illustrates the kinetic binding of anti-CD63 with host EVs at the 
concentration of c =2×1011 EVs/mL, 5×1010 EVs/mL, 1×1010 EVs/mL, 5×109 EVs/mL, and 
2×109 EVs/mL, respectively. From the kinetic binding curve, the label-free signals still 
slowly increase at the saturation region. According to the pervious study on the label-free 
sensorgrams[189, 199-201], our dynamic response curves in Figure 4-9 include both the 
binding reaction and the EV diffusion processes. In another word, the label-free detection of 
EVs via CD-63 is not a perfect reaction-limited process. 
 
Figure 4-9 Kinetic binding of anti-CD63 with host EVs at the concentration of c =2×1011 
EVs/mL, 5×1010 EVs/mL, 1×1010 EVs/mL, 5×109 EVs/mL, and 2×109 EVs/mL, respectively. 



































4.6.7 Receiver operator characteristic (ROC) analysis 
 
Figure 4-10 Statistical analyses of differentiation of host and parasitic exosome vesicles 
based on experiment data in Figure 3(c) (main text). According to the ROC curve, the PC-
based label-free assay can effectively distinguish these two different types of EVs by setting 
the threshold signal range from 0.25 nm to 0.5 nm. 
4.6.8 ELISA analysis results 
To confirm the presence of EVs and compare the LOD of our technology with the 
gold starndard, we performed the ELISA assay using a commercial CD63 ELISA kit 
(LifeSpan BioSciences, Inc., Seattle, WA). The dose-response curve of the ELISA assay is 
shwon in FigureS8. Although the LOD of the label-free EV assay (2.18×109 EVs/mL) is not 
good as the LOD of the ELISA assay (~1.07×107 EVs/mL), the label-free assay still provides 
sufficient sensitivity to distinguish different EVs. In particular, the EV samples were extract 





Figure 4-11 Dose response curve of the ELISA assay 
 Acknowledgment 
This work was supported by the United States National Science Foundation under 
Grant Nos. ECCS 17-11839 and ECCS 16-53673. Any opinions, findings, and conclusions or 
recommendations expressed in this material are those of the authors and do not necessarily 
reflect the views of National Science Foundation. This work was supported by an HIH R21 
award (AI117204) to MJK. The authors thank the Nano Fabrication Centre at the University 
of Minnesota for the support of device fabrication. YW acknowledges the Catron Center for 
Solar Energy Research for the Carton Graduate Fellowship. 




















CHAPTER 5.    EXOSOME MICROARRAY BASED ON LABEL-FREE IMAGING 
BIOSENSOR 
 Abstract 
Exosome vesicles (EVs) released by macrophages are potential biomarkers for the 
analysis of immune responses. This study reports a high-throughput EV detection assay 
developed using a label-free EV microarray. The EV microarray consists of a panel of seven 
antibodies that are specific to multiple membrane receptors of the target EVs. The EV 
microarray was fabricated on a photonic crystal (PC) biosensor surface. The hyperspectral 
imaging approached was implemented to quantify the antibody and EV absorptions on the 
PC-based microarray. The label-free EV microarray enables low-cost, rapid, and high-
throughput characterization of macrophage EVs with a significantly reduced sample volume 
of 5 μL. 
 Introduction 
Cancer cells secrete cytokines, chemokines and nucleic acids that have traditionally 
served as biomarkers for disease diagnosis and prognosis. Profoundly, membranous 
extracellular vesicles, including nanoscale exosomes (~100 nm) and other vesicles actively 
secreted from cancer cells, have also been found in the blood of cancer patients [157-159]. In 
particular, exosomes carry molecular constituents of their originating cells, including 
transmembrane and cytosolic proteins, mRNA, DNA, and microRNA (miRNA), and thus can 
serve as cellular surrogates [202, 203]. Exosome analysis is minimally invasive and less 
affected by the scarcity of samples or intratumorally heterogeneity [204]. Recent studies 
showed that exosomes vesicles (EVs) can transport a variety of molecular constituents, such 
as proteins, mRNA, and microRNAs, from their originating cells [205]. The analysis of 
circulating EVs in body fluids has emerged as a promising non-invasive molecular diagnostic 
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method [17, 206]. The EVs secreted by macrophages are particularly interesting since the 
macrophage-derived EVs may play a role in immune system responses that can influence the 
inflammatory response [83, 207]. The objective of the present research is to investigate the 
effect of exosomes released by lipopolysaccharide (LPS), -induced macrophages on gene 
expression and cell metabolism of adipocytes, focusing on the differential exosomal miRNA 
pattern between native and LPS-induced macrophages [207, 208]. LPS, an outer membrane 
component of Gram-negative bacteria, is a potent activator of monocytes and macrophages. 
Induced macrophages undergo many changes which allow them to kill invading bacteria or 
infected cells. They release toxic chemicals and proteins which have toxic effects on other 
cells.  
Existing comprehensive molecular profiling of exosomes is time-consuming and low-
throughput [205, 209, 210]. Currently, analyzing extracellular vesicles requires large 
quantities of vesicles to be prepared and concentrated for immunoblotting or enzyme-linked 
immunosorbent assay (ELISA) assays [168, 170]. Fluorescence-based approaches, such as 
bead-based assay, have the multiplexing capability and high sensitivity, but require excessive 
volumes of serum. In contrast, in order to overcome the challenges of current exosome 
analysis paradigms exosome analyses, label-free EV analysis have been demonstrated as 
effective tools for measuring an increasingly diverse range of cellular because they can offer 
simplified assays by reducing time-consuming labeling processes. The label-free EV 
microarray is built upon a photonic crystal (PC) biosensor in conjunction with the 
hyperspectral imaging approach[28, 58, 60, 80].  
To analyze the transmembrane receptors carried by EVs, this study demonstrates the 
EV microarray assay based on the label-free PC biosensor. The PC biosensor, consisting of a 
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sub-wavelength grating, is essentially a narrowband optical reflector that reflects a particular 
wavelength of a broadband excitation. The capture of EVs on the biosensor increases the 
refractive index on the sensor surface and results in a change in the light reflectance of the 
PC. Our microarray assay is designed to simultaneously measure seven membrane proteins 
of the macrophage-derived EVs using their corresponding antibodies printed on the EV 
microarray. 
 
Figure 5-1 Schematic flowchart of the isolation and detection of EVs using the PC biosensor. 
(a) Secretion of EVs from microphages. (b) EVs are separated from cell culture of 
macrophages using centrifuge. The extracted EVs are re-suspended in buffer for the 
subsequent label-free EV analysis. (c) Schematic diagram of the label-free detection of EVs 
using the PC biosensor that is functionalized with antibody to recognize the target EV (purple 
dots). (d) Measured transmission spectra before and after the binding of EVs. The spectral 
position of the minimal transmission represents the resonance wavelength. (e) SEM images 
of the PC surface before (top) and after (bottom) the immobilization. Scale bar: 800 nm. 
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 Results 
5.3.1 EV samples extracted from macrophages 
This study developed the label-free EV microarray to investigate two different types 
of EVs that were secreted by the native microphage and lipopolysaccharide (LPS)-induced 
macrophage as illustrated in Figure 5-1(a). Macrophages play a key role in LPS‐induced 
sepsis. However, the molecular comparison of exosomes derived from LPS‐induced 
macrophage has not been well analyzed. The macrophage-derived EV (EVnat) is featured 
with CD63 antigen on its surface. The LPS-treated macrophage-EVs (EVLPS) carries different 
antigens compared with the control EVnat. Figure 5-1(b) shows the process of EV isolation 
from the culture medium by centrifugation and resuspension. The details of the materials and 
supplies are given in the Methods and Material section. 
5.3.2 Label-free EV microarray built on PC biosensor 
The PC biosensor used in this study consists of a one-dimensional (1D) plastic 
grating substrate coated with a thin film of titanium oxide (TiO2). The cross section of a PC 
biosensor is schematically shown in Figure 5-1(c). Illuminated by a broadband source, the 
PC substrate exhibits narrowband optical resonances owing to the guided mode resonance 
effect[38, 211]. The resonances present as the dips in the transmission spectra (Figure 
5-1(d)). The spectral signatures, including the resonance wavelength (λr) and linewidth, have 
been exploited for the detection of chemicals and biomolecules[16, 17, 55, 127, 188, 198, 
212, 213]. On the surface of a PC biosensor, the absorption of the analyte, such as DNAs, 
proteins, EVs, or cells, can result in a resonance wavelength shift (Δλr) and the shift is 
proportional to the analyte concentration[182, 214-216].  
Details of the PC fabrication are described in the Methods and Material section. In 
brief, the plastic 1D grating structure was fabricated using the nano-replica molding 
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method[217]. Following the replica molding, the 100-nm-thick TiO2 thin film was deposited 
on the plastic grating by electron beam evaporation. To be specific to a target analyte, the 
sensor surface needs to be functionalized using the corresponding ligand. For the detection of 
EVs, the PC biosensors were coated using the antibodies that bind specifically to the EV 
membrane antigens. Figure 5-1(e) and Figure 5-1(f) shows the scanning electron microscope 
(SEM) images of the PC surface without (top) and with (bottom) absorbing EVs. The 
average size of EV is approximately 100 nm. The binding of EV and antibody can redshift 
the transmission dip by the amount of Δλr as shown in Figure 5-1(d).  
 
Figure 5-2 Fabricated EV microarray. (a) SEM image of the array of 60-µm-diameter 
microwells patterned on the PC substrate using photolithography. Scale bar: 300 µm (b) SEM 
image of a single microwell with the grating pattern at the bottom. Scale bar: 15 µm (c) List of 
the printed antibodies and references with the corresponding row numbers. (d) Method to 
calculate the resonance wavelength shift for the antibodies. 
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To achieve the simultaneous measurement of multiple membrane proteins carried by 
the EVs, the microarray was designed and fabricated on the PC substrate. The EV microarray 
was prepared in two steps. Firstly, the array of microwells was patterned in a layer of 
photoresist on the PC substrate by photolithography. Figure 5-2(a) shows the EV microarray 
with 11 × 12 microwells. The diameter and period of the microwell array are 60 µm and 150 
µm, respectively. One microwell of the microarray is zoomed in and shown in Figure 5-2(b). 
The inset SEM image elaborates the PC grating at the bottom of a microwell. Secondly, a 
molecular printer was used to print antibodies into the microwells [218, 219]. Before 
printing, the sensor surface inside the microwells was coated using aldehyde functional group 
to immobilize antibodies. The printings of antibodies were carried out inside an 
environmental chamber with the constant humidity of 60%. The detailed processes of the 
microarray fabrication, surface functionalization, and printing are described in the Methods 
and Material section. Figure 5-2(c) lists the materials printed at different rows (from Row 1 
to 12) of the microarray. For each row, the same material was printed. The capture antibodies 
anti-CD9, anti-CD63, anti-CD68, anti-CD80, anti-CD81, anti-CD86, and anti-I-A/I-E were 
chosen based on prior studies [220]. Between the nearby rows of antibodies, there was one 
blank row, which functioned as the reference spots. Figure 5-2(d) shows the method of how 
the antibody-induced resonance wavelength shift was calculated. For the row of an antibody, 
the λr value of each microwell was calculated by subtracting the λr value of the nearby 
reference microwell. For example, the λr values of microwells A2 and B2 were subtracted 
from the λr value of microwells A1 and B1, respectively. Then, the mean value of 11 
referenced microwells in the row was calculated to represent the Δλr of the specific antibody. 
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Later on, the resonance wavelength shifts caused by the blocking and EV detection steps 
were found using the λr value in the same microwell as the baseline. 
 
Figure 5-3 Hyperspectral imaging of the label-free EV microarray. (a) Schematic diagram of 
the hyperspectral imaging-based detection setup. (b) Intensity images captured at nine 
different wavelengths ranging from 830 nm to 870 nm. Each image consists of 1000 × 1000 
pixels with the spatial pixel resolution of 1.8 μm. (c) Reconstructed transmission spectrum at 
a given pixel in the area of interest. The resonance wavelength of this pixel, λr(x, y), is 
determined by a curve fitting algorithm. (d) Label-free image around one microwell. (e) 
Label-free images of EV microarray. The top panel shows the microarray before print EVs. 
The lower panel shows the microarray after printing different concentrations of EVs. Scale 
bar: 60 µm. (f) The profile plot before and after EVs treatment (black dash line and red dash 
line in (e)). Δλ represents the wavelength shift induced by the binding of EVs. 
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5.3.3 Hyperspectral imaging setup 
To measure λr values of all microwells rapidly, a hyperspectral imaging scheme was 
adopted. Figure 5-3(a) shows the hyperspectral microscopic imaging setup, whose details are 
given in the Methods and Material section. In brief, the hyperspectral imaging system was 
built on an inverted microscope and a tunable monochromatic light source. The wavelength 
of the monochromatic illumination was selected using a fiber-coupled monochromator.  The 
illumination light was collimated and polarized before it passed through the EV microarray. 
During a measure, the wavelength was scanned in the vicinity of the PC resonance from 830 
nm to 870 nm with the incremental of 1 nm.  For each wavelength, the transmission image of 
the EV microarray was recorded by a CCD camera.  
Figure 5-3(b) shows the serial of monochromatic images captured to assemble a 
hyperspectral image data cube, which contains the spectrally dispersed intensity maps of the 
entire EV microarray. Following the data acquisition, the data cube was processed to create a 
label-free resonance image for the microarray, where a single image pixel represents an area 
on the PC biosensor and its value corresponds to the resonance wavelength shift. Figure 
5-3(c) plots the transmission intensity as a function of wavelength for a given single image 
pixel at (x, y) of the EV microarray from λ830(x, y) to λ870(x, y). The resonance wavelength 
λr(x, y) was determined by fitting the transmission curve as shown by the red dashed line in 
Figure 5-3(c).  There were 1000 × 1000 pixels in each EV microarray image and the 
resonance wavelength for all these pixels were calculated to build the label–free image. 
Figure 5-3(d) illustrates the pixelized label–free image consisting of λr(x, y) values around a 
single microwell. The blue spot and yellow area represent the regions inside the microwell 




Figure 5-4 Preparation of the label–free microarray for multiplexed EV analysis. (a) Major 
steps of the label–free EV assay. The surface functionalization, printing of multiple 
antibodies, and blocking processes are summarized in Step 1–3. Step 4 illustrates the analysis 
of EVs using the printed microarray. (b) Label–free image of the EV microarray after the 
printing of seven antibodies. Rows # 3, 6, 9, 11, and 12 are the reference spots without 
antibody. (c) Box plot of the average resonance wavelength shifts for each antibody. (d) 
Label–free image obtained after the BSA blocking. This image serves as the baseline to 
calculate the wavelength shifts induced by the binding of EVs. (e) Resonance wavelength 
shifts calculated by subtracting the resonance wavelengths before from after the BSA 
blocking. 
To characterize and calibrate the PC sensor, we measured LPS-induced EV samples 
at a dilution serial of four concentrations ranging from 2×1010 particles/mL to 2×1013 
particles/mL. The samples were diluted consecutively by a factor of ten in PBS. The PC 
sensor was functionalized using the 0.5 mg/mL CD-63 antibody. Figure 5-3(e) demonstrate 
the method we calculate the resonance wavelength shift, Δλ. The top panel shows the label–
free images for the control experiment, which not print the EVs. The bottom panel shows the 
label–free images of four concentrations of EVs from 2×1010 EVs/mL to 2×1013 EVs/mL 
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with control experiment which contain zero EVs. Each resonance images have the high 
resonance shift at the boundary because the high refractive index of photoresist with 
influence the index at the boundary, so the average of the index at the boundary will higher 
itself. Figure 5-3(f) shows the profile plot before and after EVs treatment. The black line and 
red line indicate the wavelength profile of the black dash line and red dash line in Figure 
5-3(e), respectively. The difference area (green area) between the black and red line illustrate 
the resonance shift caused by EVs. The PC sensor can measure the lowest concentration at 
2×1010 that falls in the range of the clinically relevant concentration of EVs from 1×108 to 
3×1012 particles mL-1[210, 221, 222]. 
5.3.4 Label–free EV microarray assay 
Before the PC biosensor was used for the analysis of EVs, the sensor surface was 
functionalized using a four-step process reported in our previous work[223]. Major steps of 
the label-free EV detection assay are summarized in Figure 5-4(a). The initial step (step 1 in 
Figure 5-4(a)) was the coating of a porous polymer layer (Polyvinylamine, PVA) and a 
bifunctional linker, glutaraldehyde (GA), on the cleaned blank PC microarray that can 
provide a high–density amine group. The PVA and GA coating process lasted 5 hours for 
each process and was followed by a wash using DI water. Before print solution of capture 
antibodies, the buffer solution was changed to the PBS (pH = 7.4). The capture antibodies 
were printed at the concentration of at 0.5 mg mL–1 (step 2 in Figure 5-4(a)) and were 
incubated for 4 hours. After the incubation, the microarray was washed in a phosphate 
buffered saline (PBS) solution to remove the excessive antibodies. Next, the microarray was 
blocked the unoccupied aldehyde groups on the GA layer for four hours by using the bovine 
serum albumin (BSA) solution (0.5% in 0.85% sodium chloride) to prevent non–specific 
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binding (step 3 in Figure 5-4(a)). After the BSA blocking, the PC microarray were ready for 
the measuring EV binding to the antibodies. 
During the EV detection experiment, label–free images of the array were measured 
after each step shown in Figure 5-4(a). Figure 5-4(b) shows the label–free microarray image 
measured after the printing of antibodies and before the BSA blocking step. The pseudo–
color plot represents the resonance wavelength for the pixels inside the microwells. Since the 
region out of the microwave was covered by the photoresist, the resonance wavelength of the 
region was manually set at 1000 nm. The box plot in Figure 5-4(c) shows the resonance 
wavelength shifts for the panel of antibodies, including CD–9, CD–63, CD–68, CD–80, CD–
81, CD–86, and I–A/I–E. Bars indicate mean and 25th and 75th percentiles and lines indicate 
mean ±1.5 times the interquartile range. For each antibody, the Δλr values were calculated by 
subtracting of the reference spot from the nearby sample spot to the and averaging the row of 
12 spots. Figure 5-4(d) shows the label–free microarray image measured after the BSA 
blocking step and before the EV binding step. The box plot in Figure 5-4(c) shows the 
resonance wavelength shifts for the BSA blocking step of the panel of antibodies. For the 
BSA blocking step, the Δλr values were calculated by subtracting of the spots by previous 
step (λr of antibodies) and averaging the row of 12 spots. 
5.3.5 Characterization of EVs from different microphages 
Two type of the macrophage–derived EVs sample was added and incubated on the 
EV microarray for 3 hours. The LiterSlipTM cover glass (Electron Microscope Sciences) with 
approximate 7.55 µL volume and humidity control environment system was used to incubate 
the exosome solution in order to reduce the solution evaporation. The concentration and 
volume of both the EV samples were 2×1013 particles mL–1 and 5 μL, respectively. Figure 
5-5(a) is the label–free image after the EVnon absorption. Figure 5-5(b) compares the 
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resonance wavelength shifts of EV bindings with regard to each antibody. The label–free 
image measured after the BSA blocking step was used as the baseline to calculate the 
resonance wavelength shifts. The Δλr for anti–CD68 is highest and anti–CD80 is lowest, 
which the value is 1.75 nm and 0.32 nm, respectively. Figure 5-5(c) is the label–free image 
after the EVLPS incubation and binding. The box plot in Figure 5-5(d) shows the resonance 
wavelength shifts of EV bindings for the antibodies panel. For the EVLPS, the resonance 
wavelength shift of anti–CD80 is around 1.5 nm and anti-CD9 is 0.3 nm. By compare with 
the resonance wavelength shift of the EV binding for each antibody, the Δλr of the EVnon 
present the lowest shift but the EVLPS shows the largest. According to the trend of the Δλr, it 
can easily differentiation whether the EV has LPS induced.  Figure 5-5(e) shows the 
antibodies profiling of non-induced macrophage-derived EV and LPS-induced macrophage-
derived EV. The radar chart in Figure 5-5(f) display the EVnon and EVLPS observations with 
seven different antibodies. The red area represents the EVnon and the blue area shows the 
EVLPS. The data length of a spoke is proportional to the resonance wavelength shift of the 
antibody for the data point relative to the maximum magnitude of the antibody across all data 




Figure 5-5 Characterization of multiple membrane proteins of EVs secreted by native and 
LPS-induced macrophages. (a) Label-free image of the bindings of murine macrophage-
derived EVs. (b) Box plot of the average resonance wavelength shifts caused by the binding 
of EVnat to the panel of seven antibodies. (c) Label-free image of the bindings of EVs from 
the LPS-induced macrophages. (d) Statistical analysis of the binding results of EVLPS. (e) 
Distribution profiles of membrane proteins on the EVs from native and LPS-induced 
macrophages, respectively. (f) Radar chart of wavelength shifts measured for the bindings 
between antibodies and two different types of EVs (EVnat and EVLPS).   
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 Methods and Materials 
5.4.1 Preparation of EV samples 
Murine macrophage cell line J774A.1 (TIB-67, ATCC) were cultured in Dulbecco's 
Modified Eagle Medium (DMEM) containing 10% FBS, 100 Units of penicillin, 100 µg/ml 
of streptomycin, and 2 mM L-glutamine (Sigma-Aldrich, St. Louis, MO). After being 
cultured at 37 °C with 5% CO2 for 24 hr, gently rotate the flask with the remaining medium 
to wash off the dead cells, then aspirate the medium. Wash the cells with 8-10 ml cold DPBS 
(Dulbecco’s Phosphate Buffered Saline, Thermo Fisher Scientific, Waltham, MA), then 
gently rotate the flask to wash off the dead cells, then aspirate the DPBS. Add 10 ml cold 
DPBS and leave the flask in 4℃ for 3 min. Then use cell scraper to gently detach the cells. 
Collect the cells in the DPBS to a 15 ml sterile tube. Centrifuge at 1000 rpm/min for 5 min in 
a swing bucket centrifuge. Aspirate the DPBS, resuspend the cell pellet with 600 ul culture 
medium. Transfer 100 ul of the cell suspension to a new T-75 flask with 8-10 ml culture 
medium. Usually, the cells will reach to ~90 % confluency on day 3 of sub-culturing. 
The culture medium was collected and filtered through 0.22 µm filter to remove 
macrophage and debris, and then loaded on ultracentrifuge tube. To separate EVs from the 
culture media, EV samples were centrifuged again at 120000g/min for 90 min to collect EVs. 
Then the pellet was resuspended with PBS and transferred into 1.5 ml Beckman 
ultracentrifuge tube. Then they were spinned at 55,000 rpm/min for 2 hours and the pellet 
was resuspended with PBS. All the samples were centrifuged at 4℃. The harvested EVs 
were stored in a -80 °C freezer for future use. 
The concentrations of the resuspended EV samples were measured using a 
Nanoparticle Tracking Analysis system (NanoSight LM10, Malvern Instruments, Malvern, 
UK). For EVs concentration measurement, EVs from J774 or worms were diluted 100 times 
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with PBS and loaded into the nanoparticle analyzer followed the instructions. In brief, three 
videos were recorded from each sample, each video lasts for 30 sec. Mean concentration 
were calculated based on the three videos. 
5.4.2 Fabrication of PC-based EV microarray 
The nano-replica molding technique was used to generate the sub-micron grating 
pattern. The silicon replication mold stamp was purchased from LightSmyth Technologies 
(SNS-C18-2009). This silicon stamp carriers a linear grating with the period, depth, and ridge 
width of  555.5 nm, 140 nm, and 340 nm, respecitvely. To transfer the grating pattern, a drop 
of liquid ultraviolet (UV)-curable polymer (NOA-88, Norland Products, Cranbury, NJ) was 
injected into an air gap formed between the mold and a 0.18 mm-thick glass coverslip. 
Subsequently, the UV curable polymer was crosslinked using UV light at room temperature. 
As a result, the UV-curable polymer was polymerized and the grating was formed on the 
surface of polymer. After curing, the silicon mold was carefully separated from the silicon 
stamp. The separation was facilitated by pretreatment of the mold with an anti-adhesion 
saline (Trichloro(1H,1H,2H,2H-perfluorooctyl), Sigma-Aldrich). Next, the TiO2 layer was 
deposited on the polymer grating using an electron beam evaporation (BJD-1800, Temescal). 
The thickness and refractive index of the TiO2 layer were measured using a spectral 
reflectometer (F20, Filmetrics). To tune the resonance wavelength near 850 nm, the thickness 
of the TiO2 layer was chosen as 150 nm and the refractive index of the TiO2 film was 2.2. 
The array of microwells was patterned in a 1.5-μm-thick layer of photoresist (AZ 
5214E, MicroChemicals) on the fabricated PC substrate by photolithography. Before the 
printing of antibodies, the exposed PC surface was coated with aldehyde functional group to 
immobilize antibodies. To do so, the PC sensor was treated with a diluted polyvinylamine 
solution (1:50 volume ratio in water) and soaked for 12 h, followed by washing with 
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deionized (DI) water. The PVAm was attached to the PC surface via non-covalent 
interactions, providing high-density amine groups. Next, the PC was immersed with GA 
solution (25% in water; Sigma-Aldrich) and incubated for 4 h, followed by washing with DI 
water. The GA treatment enabled subsequent covalent attachment of antibody molecules with 
exposed amine moieties. Because the binding of antibody to exosome vesicles occur at pH = 
7.4, then the PC sensors was raised by PBS solutions and ready to use. The antibodies were 
printed into the microwells using a contact printer (Nano eNabler, BioForce 
Nanosciences)[218, 219]. The antibodies were mixed with the printing buffer (Spotting 
Buffer Kit, BioForce Nanosciences) at a ratio of 50:50% (v/v). In each microwell, the sample 
volume was approximately 6 pL. 
5.4.3 Hyperspectral imaging setup 
The setup is built based on the body of a standard microscope, but in addition to 
ordinary bright field imaging, another illumination path is provided from a fiber-coupled 
broadband high-power tungsten halogen light (OceanOptics HL-2000-HP). A 
monochromator (Mini-Chrom, Optometrics Corp.) was used to scan the wavelength of the 
collimated excitation. The bandwidth of the monochromatic light was controlled using the 
slit size. The monochromatic excitation split to two light paths, one of the light paths coupled 
in a fiber and connect to a spectrometer (USB2000, OceanOptics) to get the spectra of the 
light after the monochromator. From the spectra, we can accurate find the wavelength of the 
monochromator excitation. Another light path is collimated and filtered by a polarizer to 
illuminate the PC-based EV microarray with light that is polarized with its electric field 
vector oriented perpendicular to the grating lines. The transmission image was captured using 
a microscope (IX-81, Olympus) with a 4× objective (Zeiss) and an EMCCD camera (C9100, 
Hamamatsu) with 1000 × 1000 pixel. The monochromator was tuned from 830 nm to 870 nm 
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with the increment of 0.5 nm. For each wavelength, the transmission image of the EV 
microarray was recorded by the CCD to build a data cube. The data cube can be processed to 
create a label-free resonance image for the microarray, where a single image pixel represents 
an area on the PC biosensor and its value corresponds to the resonance wavelength shift. 
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CHAPTER 6.    CONCLUSION 
In summary, optical label-free biosensors serve as a powerful detection tool to 
analyze biomolecular interactions. This type of biosensor can eliminate the effect of the 
labels on the molecular conformations and can simplify the time and effort required for assay 
development. This dissertation seeks a novel and efficient modality able to overcome the 
limitations of low detection sensitivity, slow molecules mass transfer, and poor throughput, 
that occur in the current optical label-free biosensors.  
First, we investigate the optical bound states in the continuum (BIC) of the slotted 
high-contrast grating (sHCG) structures to increase the sensitivity of the sHCG-based 
biosensors. The sHCG support BICs and high-Q resonant modes and the slot position can be 
utilized to tune the linewidth of the high-Q resonances. The eigenvalue solver can directly 
determine the BICs for different designs of the sHCG structure, and the rigorous coupled-
wave analysis is performed to investigate the high-Q resonance phenomena for both TE- and 
TM-polarized cases. 
Then, we propose a lateral flow-through optofluidic biosensor that can overcome the 
mass-transfer limitation for rapid detection of biomarkers. The HCG-based biosensor is 
fabricated using the silicon-on-insulator technology. Bonding of a polydimethylsiloxane 
slab directly onto the surface results in an ultracompact biosensor, where analyte solutions 
are restricted to flow only in the space between the nanoposts. No flow exists above the 
nanoposts. The lateral flow-through feature, in conjunction with high-Q resonance modes 
associated with optical bound states of the sHCG, offers an improved sensitivity to subtle 
molecule-bonding induced changes in refractive index. The device exhibits a resonance mode 
around 1550 nm wavelength and provides an index sensitivity of 720 nm/RIU. Biosensing is 
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conducted to detect the epidermal growth factor receptor 2 (ErbB2), a protein biomarker for 
early-stage breast cancer screening, by monitoring resonance wavelength shifts in response to 
specific analyte-ligand binding events at the metasurface. The limit of detection of the device 
is 0.7 ng mL-1 for ErbB2. 
Finally, we develop a high-throughput exosome vesicles (EVs) detection assay 
by combining the hyperspectral imaging and photonic crystal-based label-free 
microarray techniques. The EV microarray consists of a panel of seven antibodies that are 
specific to multiple membrane receptors of the target EVs. The EV microarray is fabricated 
on a photonic crystal (PC) biosensor surface. The hyperspectral imaging approached is 
implemented to quantify the antibody and EV absorptions on the PC-based microarray. The 
label-free EV microarray enables low-cost, rapid, and high-throughput characterization of 
macrophage EVs with a significantly reduced sample volume of 5 μL.  
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